PTENβ	B-GP
is	O
an	O
alternatively	O
translated	O
isoform	O
of	O
PTEN	B-GP
that	O
regulates	O
rDNA	O
transcription	O

These	O
authors	O
contributed	O
equally	O
to	O
this	O
work	O

PTEN	B-GP
is	O
a	O
critical	O
tumour	B-DS
suppressor	O
that	O
is	O
frequently	O
mutated	O
in	O
human	B-OG
cancer	B-DS
.	O

We	O
have	O
previously	O
identified	O
a	O
CUG	O
initiated	O
PTEN	B-GP
isoform	O
designated	O
PTENα	B-GP
,	O
which	O
functions	O
in	O
mitochondrial	O
bioenergetics	O
.	O

Here	O
we	O
report	O
the	O
identification	O
of	O
another	O
N	O
-	O
terminal	O
extended	O
PTEN	B-GP
isoform	O
,	O
designated	O
PTENβ	B-GP
.	O

PTENβ	B-GP
translation	O
is	O
initiated	O
from	O
an	O
AUU	O
codon	O
upstream	O
of	O
and	O
in	O
-	O
frame	O
with	O
the	O
AUG	O
initiation	O
sequence	O
for	O
canonical	O
PTEN	B-GP
.	O

We	O
show	O
that	O
the	O
Kozak	O
context	O
and	O
a	O
downstream	O
hairpin	O
structure	O
are	O
critical	O
for	O
this	O
alternative	O
initiation	O
.	O

PTENβ	B-GP
localizes	O
predominantly	O
in	O
the	O
nucleolus	O
,	O
and	O
physically	O
associates	O
with	O
and	O
dephosphorylates	O
nucleolin	B-GP
,	O
which	O
is	O
a	O
multifunctional	O
nucleolar	B-GP
phosphoprotein	I-GP
.	O

Disruption	O
of	O
PTENβ	B-GP
alters	O
rDNA	O
transcription	O
and	O
promotes	O
ribosomal	O
biogenesis	O
,	O
and	O
this	O
effect	O
can	O
be	O
reversed	O
by	O
re	O
-	O
introduction	O
of	O
PTENβ	B-GP
.	O

Our	O
data	O
show	O
that	O
PTENβ	B-GP
regulates	O
pre	O
-	O
rRNA	O
synthesis	O
and	O
cellular	O
proliferation	O
.	O

These	O
results	O
demonstrate	O
the	O
complexity	O
of	O
the	O
PTEN	B-GP
protein	O
family	O
and	O
the	O
diversity	O
of	O
its	O
functions	O
.	O

PTEN	B-GP
is	O
a	O
potent	O
tumour	B-DS
suppressor	O
involved	O
in	O
cell	O
growth	O
,	O
proliferation	O
and	O
survival	O
.	O

Here	O
the	O
authors	O
identify	O
an	O
N	O
-	O
terminal	O
extended	O
isoform	O
of	O
PTEN	B-GP
,	O
termed	O
PTENβ	B-GP
that	O
negatively	O
regulates	O
ribosomal	O
DNA	O
transcription	O
and	O
cell	O
proliferation	O
,	O
expanding	O
the	O
pleiotropic	O
functions	O
of	O
the	O
PTEN	B-GP
family	O
.	O

The	O
PTEN	B-GP
gene	O
was	O
first	O
identified	O
and	O
cloned	O
in	O
1997	O
,	O
and	O
PTEN	B-GP
protein	O
has	O
proved	O
to	O
be	O
a	O
powerful	O
tumour	B-DS
suppressor12	O
.	O

It	O
is	O
one	O
of	O
the	O
most	O
frequently	O
mutated	O
or	O
deleted	O
genes	O
in	O
cancer	B-DS
,	O
including	O
cancer	B-DS
of	I-DS
the	I-DS
brain	I-DS
,	O
breast	O
,	O
prostate	O
,	O
pancreas	O
and	O
ovary3	O
.	O

Germline	O
mutations	O
of	O
the	O
PTEN	B-GP
gene	O
lead	O
to	O
inherited	O
autosomal	B-DS
dominant	I-DS
hamartoma	I-DS
tumour	I-DS
syndromes	I-DS
,	O
including	O
Bannayan	B-DS
–	I-DS
Zonana	I-DS
syndrome4	I-DS
and	O
Cowden	B-DS
disease5	I-DS
.	O

Heterozygous	O
Pten	B-GP
deletion	O
leads	O
to	O
multiple	O
tumours	B-DS
in	O
mice	B-OG
,	O
while	O
the	O
homozygote	O
is	O
embryonically	O
lethal67	O
.	O

In	O
the	O
cytoplasm	O
,	O
PTEN	B-GP
antagonizes	O
the	O
PI3K	B-GP
-	O
AKT	B-GP
-	O
mTOR	B-GP
pathway	O
by	O
dephosphorylation	O
of	O
phosphoinositide	O
-	O
3	O
,	O
4	O
,	O
5	O
-	O
triphosphate	O
(	O
PIP3	O
)	O
8	O
.	O

Loss	O
of	O
PTEN	B-GP
function	O
leads	O
to	O
uncontrolled	O
activation	O
of	O
the	O
PI3K	B-GP
/	O
AKT	B-GP
pathway	O
,	O
which	O
stimulates	O
cell	O
growth	O
,	O
cell	O
proliferation	O
and	O
cell	O
survival	O
,	O
and	O
inhibits	O
apoptosis	O
.	O

PTEN	B-GP
also	O
accumulates	O
in	O
the	O
cell	O
nucleus	O
through	O
passive	O
diffusion	O
,	O
Ran	B-GP
-	O
MVP	B-GP
-	O
mediated	O
transport	O
and	O
mono	O
-	O
ubiquitination	O
-	O
regulated	O
mechanisms9	O
.	O

In	O
the	O
nucleus	O
,	O
PTEN	B-GP
maintains	O
genome	O
integrity	O
and	O
regulates	O
the	O
process	O
of	O
DNA	O
replication	O
through	O
regulation	O
of	O
RPA1	B-GP
,	O
MCM2	B-GP
and	O
TOP2A	B-GP
(	O
refs	O
10	O
,	O
11	O
,	O
12	O
,	O
13	O
).	O

In	O
addition	O
to	O
its	O
tumour	B-DS
suppressor	O
function	O
,	O
PTEN	B-GP
is	O
also	O
involved	O
in	O
embryonic	O
development	O
,	O
lipid	O
metabolism1415	O
,	O
Alzheimer	B-DS
'	I-DS
s	I-DS
disease16	I-DS
and	O
antiviral	O
innate	O
immunity17	O
.	O

However	O
,	O
the	O
current	O
concepts	O
of	O
PTEN	B-GP
function	O
do	O
not	O
fully	O
explain	O
the	O
multifarious	O
activity	O
of	O
this	O
protein	O
.	O

In	O
eukaryotes	B-OG
,	O
the	O
translation	O
initiation	O
codon	O
is	O
generally	O
recognized	O
and	O
selected	O
by	O
the	O
5	O
′	O
cap	O
structure	O
dependent	O
ribosomal	O
scanning	O
mechanism	O
,	O
as	O
well	O
as	O
by	O
5	O
′	O
cap	O
structure	O
independent	O
internal	O
ribosome	O
entry	O
sites	O
.	O

This	O
scanning	O
complex	O
rigorously	O
controls	O
the	O
fidelity	O
of	O
initiation	O
through	O
recognition	O
of	O
the	O
correct	O
AUG	O
triplet	O
in	O
the	O
optimum	O
context	O
GCC	O
(	O
A	O
/	O
G	O
)	O
CCAUGG	O
,	O
referred	O
to	O
as	O
the	O
Kozak	O
sequence	O
,	O
which	O
includes	O
a	O
purine	O
at	O
the	O
−	O
3	O
and	O
a	O
G	O
at	O
the	O
+	O
4	O
position	O
(	O
relative	O
to	O
the	O
A	O
of	O
the	O
AUG	O
codon	O
,	O
which	O
is	O
designated	O
+	O
1	O
)	O
(	O
refs	O
18	O
,	O
19	O
).	O

Triplets	O
that	O
differ	O
from	O
AUG	O
by	O
only	O
one	O
nucleotide	O
can	O
also	O
direct	O
initiation	O
of	O
polypeptide	O
chain	O
synthesis	O
in	O
mammalian	O
cells	O
in	O
an	O
optimum	O
context20	O
.	O

It	O
is	O
also	O
reported	O
that	O
recognition	O
of	O
non	O
-	O
AUG	O
codons	O
is	O
strongly	O
stimulated	O
by	O
a	O
downstream	O
stem	O
-	O
loop	O
(	O
hairpin	O
)	O
structure	O
that	O
is	O
separated	O
from	O
the	O
preceding	O
initiation	O
codon	O
by	O
about	O
14	O
nucleotides21	O
.	O

Isoforms	O
initiated	O
from	O
non	O
-	O
AUG	O
codons	O
are	O
frequently	O
endowed	O
with	O
functions	O
additional	O
to	O
and	O
differing	O
from	O
the	O
canonical	O
form	O
of	O
a	O
given	O
protein2223	O
.	O

Previously	O
,	O
we	O
and	O
others	O
reported	O
that	O
a	O
CUG	O
codon	O
in	O
the	O
5	O
′	O
untranslated	O
region	O
(	O
5	O
′	O
UTR	O
)	O
of	O
PTEN	B-GP
mRNA	O
initiates	O
an	O
N	O
-	O
terminal	O
extended	O
isoform	O
of	O
PTEN	B-GP
now	O
known	O
as	O
PTENα	B-GP
(	O
refs	O
24	O
,	O
25	O
).	O

In	O
the	O
current	O
study	O
we	O
describe	O
another	O
PTEN	B-GP
isoform	O
designated	O
PTENβ	B-GP
,	O
which	O
comprises	O
an	O
extended	O
N	O
-	O
terminal	O
extension	O
of	O
146	O
amino	O
acids	O
(	O
Homo	B-OG
sapiens	I-OG
)	O
as	O
compared	O
with	O
canonical	O
PTEN	B-GP
protein	O
.	O

Our	O
data	O
show	O
PTENβ	B-GP
localizes	O
specifically	O
in	O
the	O
nucleolus	O
and	O
negatively	O
regulates	O
rDNA	O
transcription	O
.	O

Disruption	O
of	O
PTENβ	B-GP
leads	O
to	O
an	O
abnormal	O
increase	O
in	O
pre	O
-	O
rRNA	O
synthesis	O
and	O
results	O
in	O
promotion	O
of	O
cellular	O
proliferation	O
.	O

These	O
findings	O
characterize	O
an	O
N	O
-	O
terminal	O
extended	O
PTEN	B-GP
isoform	O
with	O
distinct	O
localization	O
and	O
function	O
,	O
which	O
results	O
from	O
alternative	O
AUU	O
translation	O
initiation	O
.	O

Identification	O
of	O
PTENβ	B-GP
further	O
reveals	O
the	O
diversity	O
of	O
PTEN	B-GP
protein	O
family	O
function	O
,	O
and	O
the	O
correspondence	O
of	O
protein	O
function	O
with	O
isoform	O
subtype	O
.	O

Results	O

An	O
unidentified	O
protein	O
is	O
recognized	O
by	O
a	O
PTENα	B-GP
antibody	B-GP

The	O
protein	O
PTENα	B-GP
functions	O
in	O
mitochondrial	O
metabolism	O
,	O
and	O
structurally	O
distinct	O
compounds	O
such	O
as	O
acriflavin	O
and	O
aurin	O
tricarboxylic	O
acid	O
(	O
ATA	O
)	O
yield	O
different	O
results	O
in	O
regulation	O
of	O
PTENα	B-GP
synthesis	O
initiated	O
by	O
a	O
CUG	O
start	O
codon25	O
.	O

The	O
CUG	O
inhibitor	O
acriflavin	O
reduces	O
PTENα	B-GP
expression	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
without	O
affecting	O
canonical	O
PTEN	B-GP
expression	O
.	O

We	O
observed	O
that	O
a	O
full	O
length	O
PTEN	B-GP
antibody	B-GP
reacted	O
with	O
an	O
unidentified	O
protein	O
of	O
molecular	O
weight	O
lower	O
than	O
PTENα	B-GP
(	O
around	O
70	O
kDa	O
),	O
and	O
expression	O
of	O
this	O
protein	O
showed	O
dose	O
dependent	O
variation	O
under	O
acriflavin	O
treatment	O
parallel	O
to	O
that	O
of	O
PTENα	B-GP
(	O
Fig	O
.	O
1a	O
).	O

A	O
panel	O
of	O
cancer	B-DS
cell	O
lines	O
was	O
examined	O
to	O
determine	O
whether	O
differences	O
in	O
PTEN	B-GP
status	O
affect	O
this	O
unidentified	O
PTEN	B-GP
-	I-GP
like	I-GP
protein	I-GP
,	O
and	O
the	O
protein	O
was	O
undetectable	O
in	O
PTEN	B-GP
-	O
null	O
PC3	O
cells	O
(	O
Fig	O
.	O
1b	O
).	O

This	O
protein	O
was	O
also	O
recognized	O
by	O
a	O
monoclonal	O
antibody	B-GP
against	O
the	O
PTEN	B-GP
C	O
-	O
terminal	O
domain	O
,	O
suggesting	O
its	O
C	O
-	O
terminal	O
region	O
is	O
similar	O
to	O
or	O
identical	O
with	O
canonical	O
PTEN	B-GP
.	O

In	O
order	O
to	O
confirm	O
this	O
,	O
we	O
examined	O
cancer	B-DS
cell	O
lines	O
with	O
an	O
anti	O
-	O
PTENα	B-GP
antibody	B-GP
raised	O
in	O
our	O
laboratory	O
by	O
immunization	O
with	O
purified	O
recombinant	O
protein	O
composed	O
of	O
the	O
173	O
N	O
-	O
terminal	O
amino	O
acids	O
of	O
PTENα	B-GP
(	O
ref	O
.	O
25	O
).	O

This	O
unidentified	O
protein	O
was	O
recognized	O
by	O
this	O
anti	O
-	O
PTENα	B-GP
antibody	B-GP
(	O
Fig	O
.	O
1c	O
),	O
indicating	O
that	O
it	O
was	O
most	O
likely	O
another	O
N	O
-	O
terminally	O
extended	O
PTEN	B-GP
variant	O
generated	O
by	O
initiation	O
at	O
an	O
in	O
-	O
frame	O
initiation	O
codon	O
within	O
the	O
PTEN	B-GP
mRNA	O
5	O
′	O
leader	O
.	O

We	O
designated	O
this	O
PTEN	B-GP
-	I-GP
like	I-GP
protein	I-GP
PTENβ	B-GP
.	O

Alternative	O
initiation	O
of	O
PTENβ	B-GP
translation	O
from	O
AUU594	O

Evaluation	O
of	O
the	O
5	O
′	O
UTR	O
of	O
human	B-OG
PTEN	B-GP
mRNA	O
for	O
alternative	O
translation	O
start	O
sites	O
in	O
frame	O
with	O
the	O
AUG1032	O
start	O
codon	O
revealed	O
a	O
total	O
of	O
four	O
non	O
-	O
AUG	O
alternative	O
initiation	O
codons	O
in	O
favourable	O
Kozak	O
contexts	O
(	O
Fig	O
.	O
2a	O
).	O

Translation	O
from	O
AUU594	O
or	O
UUG621	O
is	O
expected	O
to	O
encode	O
larger	O
forms	O
of	O
PTEN	B-GP
of	O
549	O
or	O
540	O
amino	O
acids	O
respectively	O
,	O
with	O
predicted	O
molecular	O
weights	O
of	O
61	O
.	O
6	O
–	O
62	O
.	O
9	O
kDa	O
.	O

A	O
protein	O
of	O
this	O
size	O
should	O
migrate	O
under	O
gel	O
electrophoresis	O
at	O
around	O
70	O
kDa	O
,	O
matching	O
the	O
observed	O
PTENβ	B-GP
band	O
.	O

To	O
determine	O
whether	O
one	O
of	O
these	O
non	O
-	O
AUG	O
codons	O
initiates	O
translation	O
of	O
this	O
putative	O
PTENβ	B-GP
protein	O
with	O
upstream	O
extension	O
of	O
the	O
open	O
reading	O
frame	O
(	O
ORF	O
),	O
the	O
coding	O
sequence	O
of	O
PTENα	B-GP
was	O
cloned	O
into	O
a	O
plasmid	O
with	O
a	O
C	O
-	O
terminal	O
GFP	B-GP
tag	O
(	O
Fig	O
.	O
2b	O
,	O
upper	O
panel	O
).	O

As	O
expected	O
,	O
the	O
CUG513	O
initiated	O
PTENα	B-GP
ORF	O
was	O
translated	O
into	O
three	O
distinct	O
proteins	O
with	O
masses	O
of	O
120	O
+	O
kDa	O
(	O
PTENα	B-GP
-	O
GFP	B-GP
),	O
120	O
kDa	O
(	O
PTENβ	B-GP
-	O
GFP	B-GP
)	O
and	O
90	O
kDa	O
(	O
PTEN	B-GP
-	O
GFP	B-GP
)	O
(	O
Fig	O
.	O
2b	O
,	O
lower	O
panel	O
).	O

This	O
suggested	O
that	O
PTENβ	B-GP
is	O
translated	O
from	O
a	O
new	O
ORF	O
in	O
the	O
5	O
′	O
UTR	O
of	O
PTEN	B-GP
mRNA	O
upstream	O
of	O
the	O
canonical	O
AUG	O
start	O
codon	O
.	O

To	O
identify	O
PTENβ	B-GP
translation	O
initiation	O
sites	O
,	O
a	O
plasmid	O
was	O
constructed	O
to	O
express	O
CUG513	O
-	O
initiated	O
PTENα	B-GP
with	O
a	O
C	O
-	O
terminal	O
GFP	B-GP
tag	O
,	O
and	O
mutations	O
were	O
created	O
in	O
this	O
plasmid	O
to	O
determine	O
which	O
non	O
-	O
AUG	O
codon	O
is	O
critical	O
for	O
PTENβ	B-GP
expression	O
(	O
Fig	O
.	O
2c	O
).	O

Mutation	O
of	O
CUG513	O
into	O
a	O
non	O
-	O
initiating	O
CUC	O
triplet	O
led	O
only	O
to	O
disappearance	O
of	O
the	O
most	O
slowly	O
migrating	O
proteoform	O
PTENα	B-GP
,	O
thus	O
excluding	O
the	O
possibility	O
that	O
PTENβ	B-GP
is	O
a	O
cleavage	O
product	O
(	O
Fig	O
.	O
2d	O
,	O
lane	O
4	O
).	O

On	O
the	O
basis	O
of	O
CUG513	O
mutation	O
,	O
potential	O
non	O
-	O
AUG	O
codons	O
(	O
AUU594	O
,	O
UUG621	O
)	O
were	O
mutated	O
separately	O
to	O
a	O
non	O
-	O
initiating	O
CUC	O
triplet	O
.	O

Anti	O
-	O
GFP	B-GP
immunoblots	O
from	O
these	O
transfected	O
lysates	O
revealed	O
that	O
mutation	O
of	O
AUU594	O
abolishes	O
PTENβ	B-GP
,	O
whereas	O
mutation	O
of	O
UUG621	O
has	O
no	O
such	O
effect	O
(	O
Fig	O
.	O
2d	O
,	O
lane	O
6	O
versus	O
lane	O
5	O
).	O

These	O
results	O
indicate	O
that	O
AUU594	O
but	O
not	O
UUG621	O
is	O
essential	O
for	O
PTENβ	B-GP
expression	O
,	O
and	O
that	O
AUU594	O
is	O
likely	O
the	O
translation	O
initiation	O
site	O
for	O
PTENβ	B-GP
.	O

AUU594	O
resides	O
in	O
a	O
favourable	O
Kozak	O
context	O
as	O
noted	O
(	O
GUCACCAUU594	O
)	O
(	O
Fig	O
.	O
2a	O
).	O

In	O
order	O
to	O
determine	O
whether	O
this	O
context	O
influences	O
translation	O
initiation	O
at	O
AUU594	O
,	O
we	O
constructed	O
mutants	O
to	O
disrupt	O
it	O
and	O
examined	O
PTENβ	B-GP
expression	O
(	O
Fig	O
.	O
2e	O
).	O

Disruption	O
of	O
this	O
Kozak	O
context	O
markedly	O
reduced	O
PTENβ	B-GP
expression	O
(	O
Fig	O
.	O
2f	O
),	O
strongly	O
suggesting	O
that	O
translation	O
initiation	O
of	O
PTENβ	B-GP
is	O
reliant	O
on	O
the	O
Kozak	O
context	O
.	O

Detailed	O
evaluation	O
of	O
the	O
5	O
′	O
UTR	O
of	O
human	B-OG
PTEN	B-GP
mRNA	O
revealed	O
a	O
12	O
bp	O
perfect	O
palindromic	O
sequence	O
starting	O
18	O
bp	O
downstream	O
of	O
AUU594	O
,	O
and	O
phylogenetic	O
analysis	O
suggests	O
that	O
this	O
secondary	O
structure	O
is	O
evolutionarily	O
conserved	O
(	O
Fig	O
.	O
2g	O
).	O

As	O
shown	O
in	O
Fig	O
.	O
2h	O
,	O
disruption	O
of	O
this	O
palindromic	O
motif	O
by	O
mutation	O
led	O
to	O
a	O
marked	O
reduction	O
of	O
PTENβ	B-GP
without	O
affecting	O
canonical	O
PTEN	B-GP
expression	O
(	O
lower	O
panel	O
,	O
lane	O
4	O
versus	O
lane	O
3	O
),	O
indicating	O
this	O
sequence	O
is	O
critical	O
for	O
translation	O
initiation	O
of	O
PTENβ	B-GP
.	O

These	O
data	O
demonstrate	O
that	O
PTENβ	B-GP
synthesis	O
relies	O
on	O
an	O
alternative	O
translation	O
initiation	O
at	O
the	O
AUU594	O
codon	O
,	O
and	O
expression	O
of	O
PTENβ	B-GP
is	O
influenced	O
both	O
by	O
the	O
Kozak	O
context	O
and	O
by	O
the	O
secondary	O
structure	O
downstream	O
of	O
AUU594	O
.	O

Mass	O
spectrometry	O
analysis	O
of	O
the	O
PTENβ	B-GP
sequence	O

Mass	O
spectrometry	O
was	O
used	O
for	O
peptide	O
sequencing	O
to	O
validate	O
the	O
PTENβ	B-GP
translation	O
initiation	O
site	O
.	O

Purified	O
human	B-OG
PTENβ	B-GP
with	O
a	O
C	O
-	O
terminal	O
His	O
tag	O
(	O
Fig	O
.	O
3a	O
)	O
was	O
expressed	O
in	O
Sf9	O
insect	B-OG
cells	O
for	O
mass	O
spectrometry	O
(	O
Fig	O
.	O
3b	O
).	O

Mascot	O
reports	O
revealed	O
three	O
peptide	O
fragments	O
covering	O
39	O
.	O
04	O
%	O
of	O
the	O
N	O
-	O
terminal	O
region	O
of	O
PTENβ	B-GP
(	O
from	O
AUU594	O
to	O
AUG1032	O
)	O
(	O
Fig	O
.	O
3b	O
).	O

LC	O
-	O
MS	O
/	O
MS	O
captured	O
MSRAGNAGE	O
,	O
which	O
is	O
the	O
most	O
proximal	O
N	O
-	O
terminal	O
peptide	O
of	O
PTENβ	B-GP
(	O
9	O
aa	O
,	O
MS	O
/	O
MS	O
spectrum	O
shown	O
in	O
Fig	O
.	O
3c	O
).	O

Additional	O
analysis	O
showed	O
that	O
the	O
first	O
N	O
-	O
terminal	O
amino	O
acid	O
of	O
PTENβ	B-GP
is	O
acetylated	O
.	O

These	O
mass	O
spectrum	O
data	O
therefore	O
verified	O
AUU594	O
is	O
the	O
PTENβ	B-GP
translation	O
initiation	O
site	O
.	O

The	O
5	O
′	O
UTR	O
of	O
Homo	B-OG
sapiens	I-OG
PTEN	B-GP
and	O
Mus	B-OG
musculus	I-OG
Pten	B-GP
are	O
highly	O
homologous	O
as	O
shown	O
in	O
our	O
recent	O
study25	O
,	O
suggesting	O
that	O
PTENβ	B-GP
expression	O
in	O
mice	B-OG
is	O
conserved	O
and	O
has	O
a	O
similar	O
alternative	O
translation	O
initiation	O
mechanism	O
.	O

We	O
previously	O
generated	O
a	O
FLAG	O
-	O
knockin	O
mouse	B-OG
model	O
(	O
PtenFLAG	O
),	O
in	O
which	O
the	O
C	O
-	O
terminus	O
of	O
the	O
Pten	B-GP
gene	O
was	O
targeted	O
for	O
insertion	O
of	O
a	O
FLAG	O
-	O
coding	O
sequence25	O
.	O

To	O
verify	O
PTENβ	B-GP
resides	O
at	O
the	O
Pten	B-GP
gene	O
locus	O
,	O
tissue	O
samples	O
were	O
extracted	O
from	O
heterozygous	O
PtenFLAG	O
mice	B-OG
and	O
wild	O
-	O
type	O
control	O
mice	B-OG
for	O
FLAG	O
pull	O
-	O
down	O
followed	O
by	O
immunoblotting	O
with	O
an	O
anti	O
-	O
PTENα	B-GP
antibody	B-GP
raised	O
in	O
our	O
laboratory25	O
.	O

A	O
protein	O
band	O
with	O
a	O
molecular	O
weight	O
lower	O
than	O
PTENα	B-GP
which	O
was	O
similar	O
to	O
the	O
PTENβ	B-GP
band	O
identified	O
in	O
cancer	B-DS
cell	O
lines	O
was	O
detected	O
in	O
the	O
FLAG	O
elute	O
from	O
PtenFLAG	O
tissues	O
,	O
while	O
no	O
band	O
was	O
detected	O
in	O
wild	O
-	O
type	O
tissues	O
(	O
Fig	O
.	O
3d	O
).	O

The	O
existence	O
of	O
in	O
vivo	O
PTENβ	B-GP
was	O
further	O
confirmed	O
by	O
mass	O
spectrometric	O
analysis	O
of	O
a	O
FLAG	O
-	O
purified	O
70	O
+	O
kDa	O
band	O
(	O
molecular	O
weight	O
lower	O
than	O
PTENα	B-GP
)	O
from	O
PtenFLAG	O
tissues	O
.	O

Mascot	O
reports	O
revealed	O
four	O
peptide	O
fragments	O
that	O
cover	O
68	O
.	O
5	O
%	O
of	O
the	O
N	O
-	O
terminal	O
region	O
of	O
PTENβ	B-GP
(	O
Fig	O
.	O
3e	O
).	O

These	O
results	O
verified	O
the	O
existence	O
of	O
PTENβ	B-GP
in	O
vivo	O
,	O
and	O
confirmed	O
that	O
PTENβ	B-GP
and	O
PTENα	B-GP
are	O
translated	O
in	O
vivo	O
from	O
identical	O
mRNA	O
at	O
the	O
same	O
gene	O
locus	O
.	O

This	O
PtenFLAG	O
knockin	O
animal	B-OG
model	O
demonstrates	O
the	O
natural	O
occurrence	O
of	O
alternative	O
initiation	O
that	O
results	O
in	O
translation	O
of	O
PTENβ	B-GP
.	O

PTENβ	B-GP
is	O
localized	O
predominantly	O
in	O
the	O
nucleolus	O

Longer	O
protein	O
isoforms	O
resulting	O
from	O
alternative	O
translation	O
initiation	O
frequently	O
contain	O
a	O
signal	O
for	O
subcellular	O
localization	O
that	O
is	O
absent	O
in	O
shorter	O
forms2627	O
.	O

The	O
length	O
of	O
the	O
PTENβ	B-GP
protein	O
differs	O
from	O
PTENα	B-GP
and	O
PTEN	B-GP
due	O
to	O
its	O
N	O
-	O
terminal	O
extension	O
,	O
which	O
raised	O
the	O
possibility	O
that	O
PTENβ	B-GP
has	O
unique	O
subcellular	O
localization	O
and	O
special	O
function	O
.	O

Immunofluorescence	O
examination	O
of	O
the	O
subcellular	O
localization	O
of	O
PTENβ	B-GP
was	O
compared	O
with	O
PTENα	B-GP
and	O
PTEN	B-GP
.	O

Separate	O
plasmids	O
expressing	O
C	O
-	O
terminal	O
GFP	B-GP
-	O
tagged	O
PTEN	B-GP
,	O
PTENα	B-GP
or	O
PTENβ	B-GP
were	O
constructed	O
,	O
and	O
to	O
ensure	O
expression	O
of	O
only	O
a	O
single	O
isoform	O
in	O
each	O
instance	O
,	O
we	O
created	O
an	O
ATG1032	O
>	O
ATA	O
mutation	O
in	O
GFP	B-GP
-	O
tagged	O
PTENα	B-GP
and	O
PTENβ	B-GP
(	O
Fig	O
.	O
4a	O
).	O

The	O
subcellular	O
distribution	O
of	O
PTENβ	B-GP
was	O
completely	O
different	O
from	O
that	O
of	O
PTEN	B-GP
and	O
PTENα	B-GP
as	O
shown	O
in	O
Fig	O
.	O
4b	O
.	O

PTEN	B-GP
was	O
distributed	O
ubiquitously	O
in	O
both	O
the	O
nucleus	O
and	O
cytoplasm	O
,	O
while	O
PTENα	B-GP
predominately	O
showed	O
cytoplasmic	O
localization	O
.	O

In	O
contrast	O
,	O
strong	O
PTENβ	B-GP
fluorescence	O
signals	O
were	O
distributed	O
mainly	O
in	O
the	O
relatively	O
shallow	O
DAPI	O
staining	O
areas	O
of	O
the	O
nucleus	O
which	O
have	O
been	O
suggested	O
to	O
be	O
nucleolar	O
regions28	O
,	O
and	O
little	O
cytoplasmic	O
PTENβ	B-GP
localization	O
was	O
detected	O
.	O

In	O
order	O
to	O
exclude	O
the	O
possibility	O
protein	O
localization	O
was	O
influenced	O
by	O
the	O
GFP	B-GP
tag	O
,	O
PTEN	B-GP
,	O
PTENα	B-GP
and	O
PTENβ	B-GP
expression	O
plasmids	O
were	O
constructed	O
without	O
a	O
tag	O
(	O
Supplementary	O
Fig	O
.	O
1a	O
),	O
and	O
immunofluorescence	O
with	O
PTEN	B-GP
monoclonal	O
antibody	B-GP
in	O
PTEN	B-GP
null	O
cells	O
revealed	O
that	O
these	O
untagged	O
isoforms	O
have	O
subcellular	O
distribution	O
patterns	O
identical	O
to	O
the	O
GFP	B-GP
-	O
tagged	O
molecules	O
(	O
Supplementary	O
Fig	O
.	O
1b	O
,	O
c	O
).	O

UBF	B-GP
that	O
is	O
a	O
well	O
-	O
known	O
nucleolar	O
marker	O
was	O
used	O
to	O
evaluate	O
for	O
co	O
-	O
localization	O
of	O
C	O
-	O
terminal	O
GFP	B-GP
tagged	O
PTENα	B-GP
,	O
PTENβ	B-GP
or	O
PTEN	B-GP
within	O
the	O
nucleolus	O
.	O

There	O
was	O
prominent	O
co	O
-	O
localization	O
of	O
PTENβ	B-GP
with	O
this	O
marker	O
in	O
the	O
nucleolus	O
,	O
but	O
considerably	O
less	O
nucleolar	O
co	O
-	O
localization	O
was	O
detected	O
with	O
PTEN	B-GP
or	O
PTENα	B-GP
(	O
Fig	O
.	O
4c	O
).	O

This	O
extensive	O
distribution	O
of	O
PTENβ	B-GP
in	O
the	O
nucleolus	O
was	O
confirmed	O
through	O
cell	O
fractionation	O
(	O
Fig	O
.	O
4d	O
).	O

Moreover	O
,	O
we	O
demonstrated	O
that	O
the	O
N	O
-	O
terminal	O
extended	O
sequence	O
was	O
solely	O
responsible	O
for	O
PTENβ	B-GP
accumulation	O
in	O
the	O
nucleolus	O
,	O
and	O
this	O
was	O
also	O
true	O
for	O
PTENα	B-GP
localization	O
on	O
mitochondria	O
as	O
we	O
reported	O
previously	O
(	O
Supplementary	O
Fig	O
.	O
2	O
).	O

The	O
nucleolar	O
-	O
localization	O
signals	O
(	O
NoLSs	O
)	O
that	O
govern	O
nucleolar	O
localization	O
and	O
retention	O
are	O
usually	O
rich	O
in	O
arginine	O
and	O
lysine	O
residues2930	O
.	O

We	O
noted	O
a	O
series	O
of	O
poly	O
-	O
arginine	O
residues	O
in	O
the	O
N	O
-	O
terminal	O
extended	O
domain	O
of	O
PTENβ	B-GP
(	O
aa	O
20	O
–	O
25	O
),	O
which	O
is	O
evolutionarily	O
conserved	O
(	O
Supplementary	O
Fig	O
.	O
3	O
).	O

To	O
determine	O
whether	O
this	O
sequence	O
acts	O
as	O
an	O
NoLS	O
and	O
directs	O
PTENβ	B-GP
nucleolar	O
localization	O
,	O
we	O
established	O
a	O
PTENβΔR6	O
construct	O
in	O
which	O
these	O
six	O
arginines	O
were	O
deleted	O
.	O

This	O
ΔR6	O
mutation	O
was	O
remarkable	O
in	O
that	O
it	O
completely	O
abolished	O
PTENβ	B-GP
nucleolar	O
accumulation	O
(	O
Fig	O
.	O
4e	O
),	O
indicating	O
that	O
this	O
poly	O
-	O
arginine	O
sequence	O
is	O
critical	O
for	O
PTENβ	B-GP
nucleolar	O
localization	O
,	O
and	O
showing	O
that	O
it	O
functions	O
as	O
an	O
NoLS	O
.	O

These	O
results	O
indicated	O
that	O
the	O
distinctive	O
N	O
-	O
terminal	O
extension	O
sequence	O
of	O
PTENβ	B-GP
confers	O
unique	O
cellular	O
localization	O
,	O
and	O
raised	O
the	O
possibility	O
that	O
PTENβ	B-GP
is	O
involved	O
in	O
nucleolar	O
function	O
.	O

Nucleolin	B-GP
is	O
a	O
novel	O
downstream	O
target	O
of	O
PTENβ	B-GP

In	O
order	O
to	O
identify	O
potential	O
PTENβ	B-GP
targets	O
and	O
explore	O
PTENβ	B-GP
function	O
in	O
the	O
nucleolus	O
,	O
mass	O
spectrometry	O
was	O
used	O
to	O
analyse	O
the	O
results	O
of	O
S	O
-	O
tag	O
-	O
PTENβ	B-GP
pull	O
down	O
.	O

Results	O
with	O
S	O
-	O
tag	O
-	O
PTEN	B-GP
and	O
S	O
-	O
tag	O
-	O
PTENα	B-GP
were	O
analysed	O
separately	O
as	O
controls	O
.	O

Mass	O
spectrometry	O
revealed	O
that	O
PTENβ	B-GP
specifically	O
interacts	O
with	O
a	O
large	O
number	O
of	O
nucleolar	B-GP
proteins	I-GP
(	O
Supplementary	O
Fig	O
.	O
4a	O
),	O
including	O
nucleolin	B-GP
that	O
is	O
the	O
most	O
abundant	O
multifunctional	O
phosphoprotein	B-GP
of	O
the	O
nucleolus	O
.	O

Nucleolin	B-GP
is	O
comprehensively	O
involved	O
in	O
ribosome	O
biogenesis3132	O
,	O
and	O
was	O
thus	O
considered	O
to	O
be	O
a	O
potential	O
PTENβ	B-GP
target	O
(	O
Fig	O
.	O
5a	O
).	O

Interaction	O
of	O
PTENβ	B-GP
and	O
nucleolin	B-GP
was	O
demonstrated	O
by	O
reciprocal	O
immunoprecipitation	O
(	O
Fig	O
.	O
5b	O
,	O
c	O
).	O

In	O
addition	O
,	O
immunofluorescence	O
showed	O
extensive	O
co	O
-	O
localization	O
of	O
PTENβ	B-GP
with	O
nucleolin	B-GP
in	O
the	O
nucleolus	O
,	O
whereas	O
PTEN	B-GP
or	O
PTENα	B-GP
did	O
not	O
(	O
Fig	O
.	O
5d	O
),	O
further	O
confirming	O
the	O
specificity	O
of	O
the	O
interaction	O
of	O
PTENβ	B-GP
and	O
nucleolin	B-GP
.	O

To	O
identify	O
the	O
functional	O
domains	O
by	O
which	O
PTENβ	B-GP
binds	O
to	O
nucleolin	B-GP
,	O
two	O
truncated	O
forms	O
of	O
PTENβ	B-GP
were	O
constructed	O
with	O
C	O
-	O
terminal	O
S	O
-	O
tags	O
(	O
Supplementary	O
Fig	O
.	O
5a	O
).	O

Immunoprecipitation	O
demonstrated	O
that	O
the	O
N	O
-	O
terminal	O
extension	O
domain	O
of	O
PTENβ	B-GP
is	O
essential	O
for	O
interaction	O
with	O
nucleolin	B-GP
(	O
Supplementary	O
Fig	O
.	O
5b	O
).	O

These	O
data	O
show	O
PTENβ	B-GP
and	O
nucleolin	B-GP
co	O
-	O
localize	O
and	O
interact	O
each	O
other	O
.	O

Like	O
canonical	O
PTEN	B-GP
,	O
PTENβ	B-GP
contains	O
an	O
intact	O
phosphatase	B-GP
domain	O
,	O
and	O
we	O
found	O
that	O
exogenous	O
expression	O
of	O
PTENβ	B-GP
,	O
PTENα	B-GP
or	O
PTEN	B-GP
in	O
PTEN	B-GP
null	O
cells	O
all	O
efficiently	O
reduce	O
p	O
-	O
AKT	B-GP
to	O
a	O
similar	O
level	O
(	O
Supplementary	O
Fig	O
.	O
6a	O
).	O

Moreover	O
,	O
missense	O
mutations	O
in	O
the	O
phosphatase	B-GP
domain	O
of	O
PTENβ	B-GP
(	O
G275E	O
,	O
analogous	O
to	O
PTEN	B-GP
(	O
G129E	O
))	O
and	O
(	O
C270S	O
,	O
analogous	O
to	O
PTEN	B-GP
(	O
C124S	O
))	O
both	O
eliminated	O
the	O
lipid	B-GP
phosphatase	I-GP
activity	O
of	O
the	O
protein	O
(	O
Supplementary	O
Fig	O
.	O
6b	O
).	O

PTENβ	B-GP
thus	O
has	O
phosphatase	B-GP
activity	O
that	O
is	O
presumably	O
similar	O
to	O
PTENα	B-GP
and	O
canonical	O
PTEN	B-GP
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
affinity	O
for	O
nucleolin	B-GP
binding	O
was	O
largely	O
diminished	O
in	O
protein	B-GP
phosphatase	I-GP
activity	O
deficient	O
PTENβ	B-GP
mutants	O
(	O
Y284L	O
and	O
C270S	O
)	O
(	O
Fig	O
.	O
5e	O
,	O
lane	O
3	O
and	O
lane	O
5	O
versus	O
lane	O
2	O
and	O
lane	O
4	O
),	O
suggesting	O
that	O
PTENβ	B-GP
protein	B-GP
phosphatase	I-GP
activity	O
is	O
necessary	O
for	O
interaction	O
with	O
nucleolin	B-GP
.	O

This	O
further	O
indicated	O
PTENβ	B-GP
acts	O
as	O
a	O
nucleolin	B-GP
phosphatase	B-GP
.	O

In	O
order	O
to	O
clarify	O
the	O
relationship	O
of	O
PTENβ	B-GP
with	O
nucleolin	B-GP
and	O
evaluate	O
PTENβ	B-GP
function	O
in	O
the	O
nucleolus	O
,	O
somatic	O
PTENβ	B-GP
knockout	O
was	O
established	O
with	O
CRISPR	O
-	O
Cas9	B-GP
.	O

CRISPR	O
-	O
Cas9	B-GP
-	O
mediated	O
gene	O
targeting	O
eliminated	O
PTENα	B-GP
and	O
PTENβ	B-GP
without	O
affecting	O
canonical	O
PTEN	B-GP
expression	O
,	O
and	O
we	O
also	O
designed	O
a	O
specific	O
target	O
sequence	O
for	O
sole	O
knockout	O
of	O
PTENα	B-GP
as	O
a	O
control	O
(	O
Fig	O
.	O
5f	O
,	O
g	O
).	O

We	O
found	O
that	O
PTENα	B-GP
and	O
PTENβ	B-GP
double	O
knockout	O
led	O
to	O
elevation	O
of	O
nucleolin	B-GP
phosphorylation	O
levels	O
at	O
Thr84	O
,	O
which	O
is	O
one	O
of	O
the	O
XTPXKKXX	O
motifs	O
located	O
in	O
the	O
nucleolin	B-GP
N	O
-	O
terminal	O
region	O
important	O
for	O
nucleolin	B-GP
function	O
(	O
Fig	O
.	O
5h	O
).	O

Moreover	O
,	O
exogenous	O
expression	O
of	O
wild	O
-	O
type	O
PTENβ	B-GP
but	O
not	O
protein	B-GP
phosphatase	I-GP
activity	O
abolished	O
PTENβ	B-GP
efficiently	O
downregulated	O
nucleolin	B-GP
phosphorylation	O
levels	O
at	O
Thr84	O
(	O
Fig	O
.	O
5i	O
).	O

These	O
results	O
raised	O
the	O
possibility	O
that	O
PTENβ	B-GP
acts	O
as	O
a	O
nucleolin	B-GP
phosphatase	B-GP
.	O
In	O
vitro	O
dephosphorylation	O
assays	O
further	O
verified	O
Cdk1	B-GP
/	O
CyclinB1	B-GP
-	O
phosphorylated	O
nucleolin	B-GP
Thr84	O
is	O
a	O
target	O
of	O
PTENβ	B-GP
for	O
dephosphorylation	O
(	O
Fig	O
.	O
5j	O
,	O
lane	O
5	O
versus	O
lane	O
4	O
).	O

In	O
addition	O
,	O
we	O
found	O
that	O
the	O
poly	O
-	O
arginine	O
sequence	O
deleted	O
mutant	O
that	O
eliminated	O
PTENβ	B-GP
nucleolar	O
localization	O
also	O
effectively	O
abolishes	O
its	O
phosphatase	B-GP
activity	O
on	O
nucleolin	B-GP
.	O

This	O
indicates	O
that	O
PTENβ	B-GP
nucleolin	B-GP
phosphatase	B-GP
activity	O
is	O
linked	O
to	O
its	O
localization	O
in	O
the	O
nucleolus	O
(	O
Supplementary	O
Fig	O
.	O
7	O
).	O

These	O
results	O
argue	O
that	O
PTENβ	B-GP
acts	O
as	O
a	O
nucleolin	B-GP
phosphatase	B-GP
,	O
and	O
show	O
that	O
the	O
PTENβ	B-GP
–	O
nucleolin	B-GP
interaction	O
results	O
in	O
dephosphorylation	O
modification	O
of	O
nucleolin	B-GP
,	O
which	O
influences	O
its	O
function	O
.	O

PTENβ	B-GP
inhibits	O
rDNA	O
transcription	O
and	O
cell	O
proliferation	O

Nucleolin	B-GP
is	O
involved	O
in	O
almost	O
every	O
step	O
of	O
ribosome	O
biogenesis333435	O
,	O
and	O
a	O
recent	O
study	O
showed	O
the	O
most	O
prominent	O
effect	O
of	O
nucleolin	B-GP
is	O
regulation	O
of	O
rDNA	O
transcription	O
by	O
promotion	O
of	O
the	O
rDNA	O
transcription	O
complex	O
assembly	O
,	O
in	O
which	O
the	O
phosphorylation	O
status	O
of	O
nucleolin	B-GP
is	O
rigorously	O
regulated3637	O
.	O

The	O
fact	O
that	O
PTENβ	B-GP
interacts	O
with	O
nucleolin	B-GP
and	O
dephosphorylates	O
nucleolin	B-GP
at	O
Thr84	O
raised	O
a	O
question	O
as	O
to	O
whether	O
nucleolin	B-GP
mediates	O
PTENβ	B-GP
regulation	O
of	O
rDNA	O
transcription	O
,	O
and	O
thus	O
represents	O
a	O
direct	O
mechanism	O
by	O
which	O
PTENβ	B-GP
controls	O
ribosomal	O
biogenesis	O
.	O

To	O
determine	O
the	O
influence	O
of	O
PTENβ	B-GP
on	O
rRNA	O
synthesis	O
,	O
total	O
rRNA	O
levels	O
were	O
evaluated	O
by	O
gel	O
electrophoresis	O
.	O

Knockout	O
of	O
PTENα	B-GP
and	O
PTENβ	B-GP
without	O
affecting	O
PTEN	B-GP
expression	O
led	O
to	O
elevation	O
of	O
28S	O
and	O
18S	O
total	O
rRNA	O
levels	O
,	O
whereas	O
knockout	O
of	O
PTENα	B-GP
alone	O
had	O
no	O
such	O
effect	O
(	O
Fig	O
.	O
6a	O
,	O
lane	O
3	O
versus	O
lane	O
2	O
and	O
lane	O
1	O
).	O

Moreover	O
,	O
exogenous	O
expression	O
of	O
PTENβ	B-GP
but	O
not	O
PTENα	B-GP
in	O
PTENα	B-GP
and	O
PTENβ	B-GP
null	O
cells	O
efficiently	O
downregulated	O
28S	O
and	O
18S	O
rRNA	O
levels	O
(	O
Fig	O
.	O
6b	O
,	O
lane	O
3	O
versus	O
lane	O
2	O
and	O
Supplementary	O
Fig	O
.	O
8a	O
).	O

These	O
results	O
argue	O
that	O
PTENβ	B-GP
plays	O
a	O
role	O
in	O
regulation	O
of	O
rRNA	O
,	O
and	O
in	O
particular	O
is	O
involved	O
in	O
regulation	O
of	O
pre	O
-	O
rRNA	O
synthesis	O
from	O
the	O
outset	O
of	O
ribosome	O
biogenesis	O
.	O

Transcription	O
levels	O
of	O
rRNA	O
genes	O
were	O
therefore	O
evaluated	O
by	O
analysing	O
pre	O
-	O
rRNA	O
with	O
qPCR	O
in	O
PTENβ	B-GP
wild	O
-	O
type	O
and	O
knockout	O
cells	O
.	O

As	O
expected	O
,	O
45S	O
pre	O
-	O
rRNA	O
was	O
increased	O
in	O
PTENβ	B-GP
and	O
PTENα	B-GP
double	O
knockout	O
cells	O
as	O
compared	O
with	O
PTENα	B-GP
only	O
knockout	O
or	O
wild	O
-	O
type	O
cells	O
(	O
Fig	O
.	O
6c	O
).	O

To	O
determine	O
whether	O
rDNA	O
transcription	O
is	O
regulated	O
by	O
PTENβ	B-GP
,	O
a	O
pHrD	O
-	O
IRES	O
-	O
Luc	O
or	O
pGL3	O
-	O
basic	O
control	O
vector	O
was	O
transfected	O
into	O
PTENβ	B-GP
and	O
PTENα	B-GP
double	O
knockout	O
cells	O
,	O
and	O
the	O
luciferase	B-GP
reporter	O
activity	O
of	O
the	O
rDNA	O
promoter	O
was	O
measured	O
.	O

Introduction	O
of	O
PTENβ	B-GP
,	O
but	O
not	O
PTENα	B-GP
,	O
efficiently	O
downregulated	O
luciferase	B-GP
activity	O
(	O
Fig	O
.	O
6d	O
and	O
Supplementary	O
Fig	O
.	O
8b	O
).	O

These	O
results	O
indicate	O
that	O
PTENβ	B-GP
negatively	O
regulates	O
rDNA	O
transcription	O
,	O
which	O
may	O
act	O
at	O
least	O
in	O
part	O
through	O
PTENβ	B-GP
dephosphorylation	O
of	O
nucleolin	B-GP
.	O

Nucleolar	O
morphology	O
is	O
closely	O
related	O
to	O
ribosome	O
biogenesis	O
,	O
and	O
enlarged	O
nucleoli	O
are	O
typically	O
found	O
in	O
association	O
with	O
activation	O
of	O
ribosome	O
biogenesis	O
.	O

To	O
evaluate	O
alterations	O
in	O
nucleolar	O
morphology	O
,	O
silver	O
staining	O
was	O
used	O
for	O
the	O
identification	O
of	O
argyrophilic	O
nucleolar	O
organizer	O
regions	O
(	O
AgNOR	O
).	O

PTENβ	B-GP
and	O
PTENα	B-GP
double	O
knockout	O
resulted	O
in	O
greater	O
average	O
areas	O
of	O
AgNOR	O
staining	O
,	O
while	O
PTENα	B-GP
only	O
knockout	O
did	O
not	O
have	O
this	O
effect	O
(	O
Fig	O
.	O
6e	O
).	O

This	O
suggested	O
that	O
elimination	O
of	O
PTENβ	B-GP
leads	O
to	O
upregulation	O
of	O
ribosomal	O
biogenesis	O
.	O

Stimulation	O
of	O
cell	O
proliferation	O
is	O
a	O
characteristic	O
biologic	O
feature	O
of	O
nucleolin	B-GP
,	O
and	O
is	O
typically	O
associated	O
with	O
elevated	O
ribosomal	O
biogenesis	O
.	O

We	O
therefore	O
investigated	O
biologic	O
changes	O
resulting	O
from	O
regulation	O
of	O
ribosomal	O
biogenesis	O
by	O
PTENβ	B-GP
.	O

Growth	O
curves	O
showed	O
significant	O
increases	O
in	O
cell	O
growth	O
rate	O
resulting	O
from	O
PTENβ	B-GP
knockout	O
(	O
Fig	O
.	O
6f	O
).	O

This	O
activation	O
of	O
cell	O
proliferation	O
resulting	O
from	O
PTENβ	B-GP
deprivation	O
was	O
further	O
confirmed	O
by	O
S	O
phase	O
analysis	O
(	O
Fig	O
.	O
6g	O
).	O

These	O
results	O
argue	O
that	O
PTENβ	B-GP
controls	O
cellular	O
proliferation	O
and	O
may	O
act	O
through	O
a	O
mechanism	O
involving	O
negative	O
regulation	O
of	O
pre	O
-	O
rRNA	O
synthesis	O
.	O

Discussion	O

In	O
eukaryotic	O
cells	O
,	O
the	O
ribosome	O
typically	O
initiates	O
protein	O
synthesis	O
at	O
the	O
AUG	O
codon	O
closest	O
to	O
the	O
5	O
′	O
end	O
of	O
the	O
mRNA38	O
.	O

However	O
,	O
there	O
is	O
now	O
evidence	O
including	O
observations	O
from	O
our	O
previous	O
study25	O
that	O
demonstrates	O
initiation	O
of	O
protein	O
translation	O
can	O
occur	O
at	O
most	O
codons	O
which	O
differ	O
from	O
AUG	O
by	O
no	O
more	O
than	O
a	O
single	O
nucleotide	O
(	O
non	O
-	O
AUG	O
initiation	O
)	O
20	O
.	O

More	O
than	O
50	O
instances	O
of	O
non	O
-	O
AUG	O
-	O
initiated	O
N	O
-	O
terminal	O
extensions	O
have	O
been	O
predicted	O
or	O
verified	O
experimentally	O
in	O
mammals3940	B-OG
.	O

In	O
this	O
study	O
,	O
we	O
report	O
identification	O
of	O
a	O
translational	O
variant	O
of	O
PTEN	B-GP
,	O
designated	O
PTENβ	B-GP
.	O

This	O
protein	O
is	O
synthesized	O
from	O
an	O
alternative	O
translation	O
start	O
site	O
438	O
bp	O
upstream	O
of	O
the	O
AUG	O
initiation	O
sequence	O
,	O
which	O
adds	O
146	O
N	O
-	O
terminal	O
amino	O
acids	O
to	O
the	O
canonical	O
PTEN	B-GP
ORF	O
.	O

We	O
found	O
that	O
PTENβ	B-GP
specifically	O
localizes	O
in	O
the	O
nucleolus	O
and	O
inhibits	O
pre	O
-	O
rRNA	O
synthesis	O
,	O
and	O
our	O
experimental	O
evidence	O
strongly	O
suggests	O
this	O
inhibition	O
acts	O
through	O
the	O
mechanism	O
of	O
nucleolin	B-GP
dephosphorylation	O
.	O

In	O
previous	O
studies	O
both	O
our	O
group	O
and	O
Hopkins	O
et	O
al	O
.	O
independently	O
identified	O
a	O
translational	O
variant	O
of	O
PTEN	B-GP
with	O
N	O
-	O
terminal	O
extension	O
,	O
designated	O
‘	O
PTENα	B-GP
'	O
in	O
our	O
study	O
,	O
and	O
‘	O
PTEN	B-GP
-	O
long	O
'	O
by	O
Hopkins	O
et	O
al	O
.	O
24	O
.	O

These	O
have	O
proven	O
to	O
be	O
the	O
same	O
isoform	O
that	O
is	O
translated	O
from	O
a	O
CUG	O
codon	O
519	O
bp	O
upstream	O
of	O
the	O
AUG	O
initiation	O
sequence	O
of	O
canonical	O
PTEN	B-GP
(	O
refs	O
24	O
,	O
25	O
).	O

In	O
addition	O
to	O
the	O
initiation	O
sites	O
for	O
PTENα	B-GP
and	O
PTENβ	B-GP
(	O
CUG513	O
,	O
AUU594	O
),	O
we	O
found	O
another	O
two	O
alternative	O
non	O
-	O
AUG	O
codons	O
in	O
favourable	O
Kozak	O
contexts	O
,	O
which	O
may	O
be	O
sites	O
for	O
initiation	O
of	O
other	O
as	O
yet	O
unidentified	O
isoforms	O
.	O

As	O
multiple	O
additional	O
forms	O
of	O
PTEN	B-GP
may	O
exist	O
,	O
we	O
consider	O
it	O
to	O
be	O
prudent	O
to	O
designate	O
PTEN	B-GP
isoforms	O
as	O
a	O
sequential	O
series	O
,	O
using	O
α	O
,	O
β	O
,	O
γ	O
,	O
δ	O
as	O
labels	O
.	O

In	O
eukaryotes	B-OG
,	O
the	O
efficiency	O
of	O
initiation	O
depends	O
on	O
the	O
Kozak	O
context41	O
which	O
encompasses	O
the	O
AUG	O
codon	O
.	O

Our	O
data	O
show	O
that	O
initiation	O
of	O
PTENβ	B-GP
relies	O
on	O
the	O
Kozak	O
context	O
surrounding	O
AUU594	O
,	O
which	O
suggests	O
this	O
context	O
is	O
also	O
essential	O
for	O
efficient	O
initiation	O
of	O
other	O
non	O
-	O
AUG	O
codons	O
.	O

We	O
identified	O
a	O
12	O
bp	O
perfect	O
palindromic	O
sequence	O
starting	O
18	O
bp	O
downstream	O
of	O
AUU594	O
,	O
and	O
showed	O
that	O
disruption	O
of	O
this	O
conserved	O
palindrome	O
sharply	O
downregulates	O
expression	O
of	O
PTENβ	B-GP
.	O

The	O
crucial	O
role	O
this	O
downstream	O
palindromic	O
sequence	O
plays	O
in	O
AUU	O
-	O
mediated	O
initiation	O
,	O
together	O
with	O
discovery	O
of	O
the	O
fact	O
in	O
our	O
previous	O
study	O
that	O
the	O
CUG	O
centred	O
palindromic	O
sequence	O
may	O
be	O
a	O
signature	O
motif	O
for	O
alternative	O
Leu	O
-	O
tRNA	O
initiation25	O
,	O
underscores	O
the	O
importance	O
of	O
secondary	O
structure	O
for	O
non	O
-	O
AUG	O
initiation	O
.	O

This	O
is	O
consistent	O
with	O
the	O
concept	O
that	O
a	O
strong	O
secondary	O
structure	O
downstream	O
of	O
the	O
non	O
-	O
AUG	O
codon	O
may	O
significantly	O
increase	O
initiation	O
efficiency	O
as	O
reported	O
by	O
Kozak42	O
.	O

We	O
previously	O
showed	O
that	O
PTENα	B-GP
localizes	O
in	O
mitochondria	O
and	O
functions	O
in	O
mitochondrial	O
metabolism25	O
.	O

Hopkins	O
et	O
al	O
.	O
reported	O
that	O
PTEN	B-GP
-	O
long	O
(	O
designated	O
PTEN	B-GP
-	O
L	O
)	O
is	O
secreted	O
into	O
adjacent	O
cells	O
,	O
which	O
relies	O
on	O
an	O
N	O
-	O
terminal	O
secretion	O
sequence24	O
.	O

These	O
findings	O
indicate	O
that	O
the	O
N	O
-	O
terminal	O
extended	O
PTENα	B-GP
isoform	O
is	O
endowed	O
with	O
capability	O
for	O
subcellular	O
localization	O
differing	O
from	O
canonical	O
PTEN	B-GP
.	O

Data	O
in	O
the	O
current	O
study	O
show	O
that	O
there	O
is	O
partial	O
co	O
-	O
localization	O
of	O
PTEN	B-GP
and	O
PTENα	B-GP
in	O
the	O
cytoplasm	O
,	O
and	O
this	O
is	O
consistent	O
with	O
findings	O
in	O
our	O
previous	O
study	O
that	O
PTEN	B-GP
interacts	O
and	O
co	O
-	O
localizes	O
with	O
PTENα	B-GP
in	O
mitochondria25	O
.	O

However	O
,	O
PTEN	B-GP
isoforms	O
localize	O
for	O
the	O
most	O
part	O
in	O
a	O
mutually	O
exclusive	O
manner	O
(	O
Supplementary	O
Fig	O
.	O
9	O
).	O

PTENβ	B-GP
specifically	O
localizes	O
in	O
the	O
nucleolus	O
,	O
whereas	O
PTEN	B-GP
and	O
PTENα	B-GP
do	O
not	O
,	O
and	O
an	O
evolutionarily	O
conserved	O
poly	O
-	O
arginine	O
sequence	O
has	O
proven	O
to	O
be	O
an	O
NoLS	O
of	O
PTENβ	B-GP
.	O

The	O
PTENβ	B-GP
N	O
-	O
terminus	O
is	O
27	O
amino	O
acids	O
shorter	O
than	O
PTENα	B-GP
,	O
and	O
PTENβ	B-GP
therefore	O
does	O
not	O
contain	O
the	O
N	O
-	O
terminal	O
secretion	O
signal	O
sequence	O
,	O
which	O
may	O
in	O
part	O
account	O
for	O
the	O
differences	O
in	O
cellular	O
distribution	O
of	O
PTENβ	B-GP
and	O
PTENα	B-GP
.	O

Moreover	O
,	O
protein	O
conformation	O
may	O
be	O
altered	O
by	O
differences	O
in	O
the	O
length	O
of	O
the	O
N	O
-	O
terminal	O
domain	O
,	O
leading	O
to	O
differing	O
affinities	O
for	O
interacting	O
proteins	O
or	O
nucleotide	O
sequences2743	O
.	O

This	O
may	O
in	O
some	O
measure	O
explain	O
the	O
diversity	O
of	O
PTEN	B-GP
isoform	O
distribution	O
.	O

Our	O
data	O
demonstrate	O
that	O
PTENβ	B-GP
is	O
involved	O
in	O
regulation	O
of	O
pre	O
-	O
rRNA	O
synthesis	O
,	O
and	O
disruption	O
of	O
PTENβ	B-GP
results	O
in	O
elevated	O
ribosomal	O
biogenesis	O
and	O
cellular	O
proliferation	O
.	O

Our	O
findings	O
suggest	O
that	O
this	O
PTENβ	B-GP
regulatory	O
mechanism	O
may	O
act	O
through	O
dephosphorylation	O
of	O
nucleolar	O
protein	O
nucleolin	B-GP
.	O

It	O
has	O
been	O
reported	O
that	O
PTEN	B-GP
acts	O
on	O
ribosomal	O
biogenesis	O
through	O
the	O
PI3K	B-GP
-	O
mTOR	B-GP
pathway	O
by	O
downregulation	O
of	O
45S	O
pre	O
-	O
rRNA	O
and	O
that	O
PTEN	B-GP
localizes	O
to	O
the	O
nucleolus	O
to	O
regulate	O
nucleolar	O
homeostasis444546	O
.	O

However	O
,	O
our	O
results	O
indicate	O
there	O
is	O
extensive	O
distribution	O
of	O
PTENβ	B-GP
in	O
the	O
nucleolus	O
while	O
little	O
nucleolar	O
PTEN	B-GP
can	O
be	O
detected	O
.	O

The	O
PTENβ	B-GP
coding	O
sequence	O
overlaps	O
the	O
sequence	O
of	O
full	O
-	O
length	O
canonical	O
PTEN	B-GP
and	O
PTENβ	B-GP
can	O
be	O
efficiently	O
recognized	O
by	O
PTEN	B-GP
antibodies	B-GP
.	O

It	O
is	O
therefore	O
possible	O
that	O
the	O
nucleolar	O
immunofluorescence	O
signals	O
detected	O
by	O
the	O
PTEN	B-GP
monoclonal	O
antibody	B-GP
in	O
this	O
study	O
are	O
derived	O
from	O
recognition	O
of	O
this	O
previously	O
unidentified	O
PTENβ	B-GP
isoform	O
instead	O
of	O
from	O
canonical	O
PTEN	B-GP
.	O

Furthermore	O
,	O
it	O
must	O
be	O
noted	O
that	O
most	O
of	O
the	O
observations	O
from	O
the	O
studies	O
cited	O
above	O
were	O
made	O
in	O
PTEN	B-GP
knockout	O
cells	O
or	O
with	O
Pten	B-GP
deficient	O
mice	B-OG
.	O

As	O
PTEN	B-GP
and	O
its	O
isoforms	O
PTENα	B-GP
and	O
PTENβ	B-GP
are	O
coded	O
by	O
the	O
same	O
gene	O
,	O
current	O
PTEN	B-GP
knockout	O
mouse	B-OG
models	O
are	O
essentially	O
equivalent	O
to	O
at	O
least	O
triple	O
deletion	O
of	O
PTEN	B-GP
and	O
its	O
isoforms	O
.	O

The	O
phenotypic	O
deficiencies	O
of	O
PTEN	B-GP
knockout	O
models	O
may	O
thus	O
be	O
partially	O
attributed	O
to	O
loss	O
of	O
PTEN	B-GP
or	O
one	O
of	O
its	O
isoforms	O
.	O

By	O
use	O
of	O
specific	O
disruption	O
of	O
PTENβ	B-GP
,	O
our	O
study	O
reveals	O
that	O
PTENβ	B-GP
plays	O
an	O
essential	O
role	O
in	O
rDNA	O
transcription	O
and	O
regulation	O
of	O
cellular	O
proliferation	O
.	O

Several	O
recent	O
studies	O
have	O
described	O
a	O
diversity	O
of	O
nucleolar	O
functions	O
in	O
addition	O
to	O
ribosome	O
biogenesis	O
,	O
such	O
as	O
modification	O
of	O
small	O
RNAs	O
,	O
regulation	O
of	O
the	O
cell	O
cycle	O
and	O
control	O
of	O
aging4748	O
,	O
and	O
nucleolar	O
perturbations	O
have	O
been	O
observed	O
in	O
various	O
diseases	O
ranging	O
from	O
auto	O
-	O
immunity	O
to	O
cancer4950	O
.	O

Our	O
results	O
show	O
that	O
in	O
addition	O
to	O
nucleolin	B-GP
,	O
PTENβ	B-GP
may	O
physically	O
interact	O
with	O
a	O
number	O
of	O
other	O
nucleolar	B-GP
proteins	I-GP
(	O
Supplementary	O
Fig	O
.	O
4b	O
),	O
which	O
raises	O
the	O
possibility	O
that	O
it	O
participates	O
in	O
nucleolar	O
functions	O
apart	O
from	O
ribosome	O
biogenesis	O
.	O

In	O
this	O
study	O
,	O
we	O
identify	O
PTENβ	B-GP
as	O
a	O
new	O
isoform	O
of	O
PTEN	B-GP
,	O
which	O
negatively	O
regulates	O
rDNA	O
transcription	O
and	O
cellular	O
proliferation	O
.	O

Based	O
on	O
previous	O
studies	O
that	O
show	O
imbalance	O
of	O
rDNA	O
transcription	O
closely	O
correlates	O
with	O
tumour	B-DS
progression5152	O
,	O
identification	O
of	O
PTENβ	B-GP
may	O
provide	O
a	O
new	O
track	O
for	O
therapeutic	O
drug	O
design	O
.	O

These	O
results	O
together	O
with	O
our	O
previous	O
observations	O
regarding	O
PTENα	B-GP
illustrate	O
the	O
complexity	O
of	O
PTEN	B-GP
function	O
and	O
enrich	O
our	O
understanding	O
of	O
the	O
PTEN	B-GP
family	O
.	O

Methods	O

Cell	O
lines	O

All	O
human	B-OG
cell	O
lines	O
used	O
in	O
this	O
study	O
(	O
HepG2	O
,	O
H1299	O
,	O
HCT116	O
,	O
PC3	O
,	O
786	O
-	O
O	O
,	O
Hela	O
,	O
U2OS	O
,	O
HEK	O
293T	O
,	O
SMMC	O
-	O
7721	O
,	O
DU145	O
and	O
LoVo	O
)	O
were	O
from	O
the	O
American	O
Type	O
Culture	O
Collection	O
.	O

These	O
cell	O
lines	O
were	O
authenticated	O
by	O
STR	O
locus	O
analysis	O
and	O
were	O
tested	O
for	O
mycoplasma	B-OG
contamination	O
.	O

PC3	O
and	O
786	O
-	O
O	O
cells	O
were	O
maintained	O
in	O
RPMI	O
1640	O
(	O
CORNING	O
),	O
and	O
all	O
other	O
cells	O
were	O
maintained	O
in	O
DMEM	O
(	O
CORNING	O
),	O
supplemented	O
with	O
10	O
%	O
FBS	O
(	O
Hyclone	O
)	O
in	O
a	O
37	O
°	O
C	O
incubator	O
with	O
5	O
%	O
(	O
v	O
/	O
v	O
)	O
CO2	O
.	O

The	O
insect	B-OG
cell	O
line	O
Sf9	O
was	O
obtained	O
from	O
Invitrogen	O
and	O
cultured	O
in	O
Grace	O
'	O
s	O
insect	B-OG
medium	O
(	O
Gibco	O
).	O

Mice	B-OG

Tissues	O
of	O
C57BL	B-OG
/	I-OG
6	I-OG
mice25	I-OG
were	O
lysed	O
in	O
lysis	O
buffer	O
(	O
50	O
mM	O
Tris	O
-	O
pH	O
7	O
.	O
5	O
,	O
150	O
mM	O
NaCl	O
,	O
1	O
%	O
NP40	O
)	O
and	O
subjected	O
to	O
immunoblotting	O
or	O
immunoprecipitation	O
.	O

All	O
animals	B-OG
were	O
maintained	O
in	O
a	O
special	O
pathogen	O
-	O
free	O
facility	O
,	O
and	O
the	O
animal	B-OG
study	O
protocols	O
used	O
were	O
approved	O
by	O
the	O
ethics	O
committee	O
of	O
Peking	O
University	O
Health	O
Science	O
Center	O
(	O
approval	O
number	O
bjmu20110301	O
).	O

Antibodies	B-GP
and	O
reagents	O

Primary	O
antibodies	B-GP
used	O
for	O
western	O
blot	O
,	O
immunoprecipitation	O
and	O
immunofluorescence	O
are	O
listed	O
in	O
Supplementary	O
Table	O
1	O
.	O

The	O
anti	O
-	O
PTENα	B-GP
(	O
ref	O
.	O
25	O
)	O
and	O
anti	O
-	O
nucleolin	B-GP
antibodies	B-GP
were	O
raised	O
in	O
our	O
laboratory	O
(	O
Supplementary	O
Fig	O
.	O
10	O
).	O

The	O
reagent	O
Acriflavin	O
was	O
from	O
Sigma	O
,	O
A8126	O
.	O

Plasmids	O
and	O
cloning	O
strategies	O

The	O
plasmids	O
pCMV	O
-	O
tag	O
-	O
2b	O
,	O
pSA	O
,	O
pEGFP	O
-	O
N1	O
,	O
pDsRed2	O
-	O
N1	O
and	O
pFastBac1	O
were	O
purchased	O
from	O
Addgene	O
.	O

pX330	O
was	O
purchased	O
from	O
BEIJING	O
IDMO	O
CO	O
.,	O
LTD	O
.	O

pcDNA3	O
.	O
1	O
-	O
Cas9	B-GP
was	O
a	O
gift	O
from	O
Dr	O
Jianzhong	O
Xi	O
in	O
the	O
College	O
of	O
Engineering	O
,	O
Peking	O
University	O
.	O

PTEN	B-GP
,	O
PTENα	B-GP
,	O
PTENβ	B-GP
,	O
or	O
nucleolin	B-GP
or	O
truncations	O
and	O
mutations	O
of	O
these	O
molecules	O
were	O
inserted	O
into	O
these	O
plasmids	O
.	O

pHrD	O
-	O
IRES	O
-	O
Luc	O
was	O
a	O
gift	O
from	O
Dr	O
Xiaojuan	O
Du	O
in	O
the	O
Department	O
of	O
Cell	O
Biology	O
,	O
Peking	O
University	O
Health	O
Science	O
Center53	O
.	O

Mass	O
spectrometry	O

For	O
in	O
vitro	O
PTENβ	B-GP
identification	O
experiments	O
,	O
the	O
PTENβ	B-GP
coding	O
sequence	O
(	O
CUG513	O
-	O
UGA2240	O
,	O
PTENα	B-GP
initiation	O
codon	O
CUG513	O
mutated	O
to	O
CUC	O
and	O
canonical	O
PTEN	B-GP
initiation	O
codon	O
AUG1032	O
mutated	O
to	O
AUA	O
)	O
was	O
subcloned	O
with	O
a	O
C	O
-	O
terminal	O
His	O
-	O
tag	O
into	O
a	O
pFastBac1	O
vector	O
for	O
expression	O
in	O
Sf9	O
insect	B-OG
cells	O
.	O

His	O
affinity	O
chromatography	O
was	O
used	O
for	O
purification	O
of	O
PTENβ	B-GP
-	O
His	O
before	O
SDS	O
–	O
PAGE	O
resolution	O
of	O
a	O
70	O
-	O
kDa	O
band	O
.	O

Immunoprecipitated	O
proteins	O
were	O
digested	O
in	O
-	O
gel	O
by	O
endoproteinase	B-GP
Glu	I-GP
-	I-GP
C	I-GP
(	O
Promega	O
)	O
following	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Peptides	O
were	O
separated	O
by	O
online	O
reversed	O
-	O
phase	O
nanoscale	O
capillary	O
liquid	O
chromatography	O
(	O
Easy	O
-	O
nLC	O
1	O
,	O
000	O
,	O
Thermo	O
Scientific	O
).	O

The	O
data	O
dependent	O
mass	O
spectra	O
were	O
acquired	O
with	O
the	O
LTQ	O
-	O
Orbitrap	O
Elite	O
mass	O
spectrometer	O
(	O
Thermo	O
Scientific	O
)	O
equipped	O
with	O
a	O
nanoelectrospray	O
ion	O
source	O
(	O
Thermo	O
Scientific	O
).	O

Raw	O
files	O
were	O
searched	O
by	O
Proteome	O
Discoverer	O
(	O
Version	O
1	O
.	O
4	O
.	O
1	O
.	O
14	O
,	O
Thermo	O
Scientific	O
)	O
against	O
the	O
UniProt	O
Human	B-OG
database	O
supplemented	O
with	O
N	O
-	O
terminal	O
extended	O
PTEN	B-GP
sequence	O
(	O
Supplementary	O
Fig	O
.	O
11a	O
).	O

Search	O
parameters	O
were	O
set	O
as	O
follows	O
:	O
enzyme	O
with	O
semi	O
-	O
Glu	O
-	O
C	O
;	O
up	O
to	O
two	O
missed	O
cleavages	O
;	O
carbamidomethyl	O
cysteine	O
as	O
fixed	O
modification	O
;	O
methionine	O
oxidation	O
and	O
peptide	O
N	O
-	O
terminal	O
acetylation	O
as	O
variable	O
modifications	O
.	O

The	O
false	O
discovery	O
rates	O
were	O
set	O
at	O
0	O
.	O
01	O
(	O
ref	O
.	O
25	O
).	O

For	O
endogenous	O
PTENβ	B-GP
identification	O
experiments	O
,	O
a	O
FLAG	O
-	O
purified	O
70	O
kDa	O
band	O
(	O
molecular	O
weight	O
lower	O
than	O
PTENα	B-GP
)	O
from	O
PtenFLAG	O
tissues	O
was	O
treated	O
in	O
the	O
same	O
way	O
as	O
described	O
above	O
.	O

Raw	O
files	O
were	O
searched	O
with	O
Proteome	O
Discoverer	O
(	O
Version	O
1	O
.	O
4	O
.	O
1	O
.	O
14	O
,	O
Thermo	O
Scientific	O
)	O
against	O
the	O
UniProt	O
Mouse	B-OG
database	O
supplemented	O
with	O
the	O
N	O
-	O
terminal	O
extended	O
PTEN	B-GP
sequence	O
(	O
Supplementary	O
Fig	O
.	O
11b	O
).	O

For	O
peptide	O
analysis	O
of	O
pull	O
down	O
experiments	O
,	O
proteins	O
were	O
digested	O
by	O
endoproteinase	B-GP
Trypsin	B-GP
(	O
Promega	O
)	O
in	O
gel	O
following	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

The	O
following	O
process	O
was	O
the	O
same	O
as	O
described	O
above	O
.	O

Raw	O
files	O
were	O
searched	O
by	O
Proteome	O
Discoverer	O
(	O
Version	O
1	O
.	O
4	O
.	O
1	O
.	O
14	O
,	O
Thermo	O
Scientific	O
)	O
against	O
the	O
UniProt	O
Human	B-OG
database	O
.	O

Search	O
parameters	O
were	O
set	O
as	O
follows	O
:	O
enzyme	O
with	O
Trypsin	B-GP
;	O
up	O
to	O
two	O
missed	O
cleavages	O
;	O
carbamidomethyl	O
cysteine	O
as	O
fixed	O
modification	O
;	O
methionine	O
oxidation	O
as	O
variable	O
modifications	O
.	O

The	O
false	O
discovery	O
rates	O
were	O
set	O
at	O
0	O
.	O
01	O
.	O

CRISPR	O
-	O
CAS9	B-GP
-	O
mediated	O
somatic	O
PTENβ	B-GP
knockout	O

Sequences	O
(	O
ACCTCCCGCTCCTGGAGCGG	O
or	O
AGTCGCCTGTCACCATTTCC	O
)	O
of	O
the	O
human	B-OG
PTEN	B-GP
gene	O
in	O
exon1	O
were	O
targeted	O
separately	O
.	O

Oligos	O
were	O
purchased	O
from	O
Tsingke	O
and	O
ligated	O
into	O
the	O
U6	O
-	O
sgRNA	O
plasmid	O
.	O

Hela	O
cells	O
were	O
seeded	O
onto	O
24	O
-	O
well	O
plates	O
containing	O
500	O
μl	O
DMEM	O
medium	O
at	O
a	O
density	O
of	O
1	O
,	O
00	O
,	O
000	O
cells	O
per	O
ml	O
of	O
cell	O
suspension	O
.	O

200	O
ng	O
of	O
U6	O
-	O
sgRNA	O
plasmid	O
and	O
200	O
ng	O
of	O
Cas9	B-GP
plasmid	O
in	O
total	O
were	O
transfected	O
into	O
cells	O
using	O
PEI	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Medium	O
was	O
replaced	O
at	O
around	O
12	O
h	O
post	O
transfection	O
.	O

Cells	O
were	O
maintained	O
for	O
another	O
72	O
h	O
to	O
allow	O
sufficient	O
time	O
for	O
genomic	O
engineering	O
mediated	O
by	O
the	O
CRISPR	O
-	O
Cas9	B-GP
system	O
.	O

Transfected	O
cells	O
were	O
then	O
treated	O
with	O
500	O
μg	O
ml	O
−	O
1	O
of	O
G418	O
for	O
3	O
days	O
.	O

After	O
G418	O
selection	O
,	O
cell	O
clones	O
were	O
selected	O
and	O
amplified	O
for	O
mutation	O
sequencing	O
.	O

Co	O
-	O
immunoprecipitation	O

Immunoprecipitation	O
was	O
performed	O
as	O
previously	O
described12	O
.	O

In	O
brief	O
,	O
cells	O
were	O
extracted	O
and	O
lysed	O
in	O
lysis	O
buffer	O
(	O
50	O
mM	O
Tris	O
-	O
pH	O
7	O
.	O
5	O
,	O
150	O
mM	O
NaCl	O
,	O
0	O
.	O
5	O
%	O
NP40	O
)	O
freshly	O
supplemented	O
with	O
1	O
mM	O
PMSF	O
and	O
protease	B-GP
inhibitor	O
.	O

Cell	O
lysate	O
(	O
500	O
μg	O
)	O
was	O
incubated	O
with	O
antibody	B-GP
against	O
GFP	B-GP
-	O
tag	O
or	O
FLAG	O
-	O
tag	O
for	O
8	O
h	O
,	O
followed	O
by	O
incubation	O
with	O
protein	B-GP
A	I-GP
/	O
G	O
agarose	O
for	O
1	O
h	O
.	O

The	O
protein	O
-	O
bead	O
complex	O
mixture	O
was	O
washed	O
in	O
washing	O
buffer	O
containing	O
0	O
.	O
1	O
%	O
NP40	O
and	O
subjected	O
to	O
western	O
blot	O
to	O
evaluate	O
protein	O
interaction	O
.	O

Immunofluorescence	O
and	O
confocal	O
microscopy	O

HeLa	O
cells	O
were	O
seeded	O
on	O
cover	O
glass	O
in	O
DMEM	O
medium	O
followed	O
by	O
transfection	O
with	O
C	O
-	O
terminal	O
GFP	B-GP
-	O
tagged	O
PTEN	B-GP
,	O
PTENα	B-GP
or	O
PTENβ	B-GP
.	O

After	O
transfection	O
for	O
24	O
h	O
,	O
cells	O
were	O
fixed	O
with	O
4	O
%	O
PFA	O
,	O
permeabilized	O
with	O
0	O
.	O
2	O
%	O
Triton	O
X	O
-	O
100	O
and	O
blocked	O
for	O
at	O
least	O
30	O
min	O
using	O
4	O
%	O
BSA	B-GP
dissolved	O
in	O
PBS	O
+	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
(	O
PBS	O
-	O
T	O
).	O

Primary	O
antibody	B-GP
(	O
diluted	O
in	O
blocking	O
solution	O
)	O
was	O
then	O
applied	O
for	O
1	O
h	O
,	O
followed	O
by	O
five	O
washes	O
in	O
PBS	O
-	O
T	O
,	O
and	O
fluorophore	O
-	O
conjugated	O
secondary	O
antibody	B-GP
was	O
applied	O
for	O
45	O
min	O
.	O

Coverslips	O
were	O
mounted	O
and	O
cells	O
were	O
evaluated	O
with	O
fluorescence	O
microscopy	O
.	O

A	O
Nikon	O
A1	O
microscope	O
was	O
used	O
for	O
confocal	O
microscopy	O
.	O

Cell	O
fractionation	O

Nucleoli	O
were	O
isolated	O
in	O
Hela	O
cells	O
as	O
previously	O
described	O
with	O
some	O
modifications54	O
.	O

Isolated	O
nucleoli	O
were	O
lysed	O
with	O
RIPA	O
buffer	O
.	O

Equal	O
amounts	O
of	O
whole	O
cell	O
lysate	O
,	O
cytosolic	O
fraction	O
,	O
nuclear	O
plasma	O
fraction	O
and	O
nucleolar	O
fraction	O
were	O
evaluated	O
with	O
western	O
blot	O
analysis	O
.	O

Briefly	O
,	O
Hela	O
cells	O
(	O
one	O
15	O
-	O
cm	O
dish	O
)	O
were	O
scraped	O
into	O
ice	O
-	O
cold	O
PBS	O
and	O
washed	O
three	O
times	O
with	O
ice	O
-	O
cold	O
PBS	O
.	O

Cell	O
pellets	O
were	O
then	O
re	O
-	O
suspended	O
in	O
hypotonic	O
buffer	O
(	O
10	O
mM	O
Hepes	O
,	O
pH	O
7	O
.	O
9	O
,	O
10	O
mM	O
KCl	O
,	O
1	O
.	O
5	O
mM	O
MgCl2	O
,	O
0	O
.	O
5	O
mM	O
DTT	O
),	O
allowed	O
to	O
swell	O
and	O
subjected	O
to	O
Dounce	O
homogenization	O
.	O

The	O
crude	O
nuclear	O
fraction	O
was	O
recovered	O
by	O
centrifugation	O
at	O
218g	O
for	O
5	O
min	O
,	O
and	O
the	O
cytoplasmic	O
supernatant	O
was	O
retained	O
.	O

Nuclei	O
were	O
re	O
-	O
suspended	O
in	O
0	O
.	O
35	O
M	O
sucrose	O
plus	O
0	O
.	O
5	O
mM	O
magnesium	O
acetate	O
and	O
then	O
subjected	O
to	O
brief	O
sonication	O
to	O
release	O
the	O
nucleoli	O
.	O

Pellets	O
were	O
purified	O
by	O
two	O
cycles	O
of	O
centrifugation	O
through	O
0	O
.	O
88	O
M	O
sucrose	O
,	O
and	O
the	O
supernatant	O
from	O
the	O
first	O
sucrose	O
gradient	O
was	O
recovered	O
as	O
a	O
crude	O
nucleoplasmic	O
fraction	O
.	O

The	O
pellets	O
consisted	O
of	O
nucleoli	O
.	O

S	O
-	O
tag	O
pull	O
down	O
assay	O

HEK	O
293T	O
cells	O
were	O
transfected	O
with	O
pSA	O
,	O
pSA	O
-	O
PTEN	B-GP
,	O
pSA	O
-	O
PTENα	B-GP
,	O
pSA	O
-	O
PTENβ	B-GP
or	O
pSA	O
-	O
NCL	B-GP
plasmids	O
and	O
harvested	O
36	O
h	O
after	O
transfection	O
.	O

Cells	O
were	O
lysed	O
with	O
lysis	O
buffer	O
(	O
50	O
mM	O
Tris	O
pH	O
7	O
.	O
5	O
,	O
150	O
mM	O
NaCl	O
,	O
2	O
mM	O
EDTA	O
,	O
1	O
%	O
NP40	O
and	O
1	O
mM	O
NaF	O
).	O

Equal	O
amounts	O
of	O
protein	O
were	O
incubated	O
with	O
S	B-GP
protein	I-GP
agarose	O
(	O
Novagen	O
)	O
for	O
4	O
h	O
.	O

The	O
protein	O
-	O
bead	O
complexes	O
were	O
washed	O
four	O
times	O
with	O
washing	O
buffer	O
containing	O
0	O
.	O
1	O
%	O
NP40	O
.	O

After	O
boiling	O
at	O
100	O
°	O
C	O
in	O
loading	O
buffer	O
,	O
proteins	O
were	O
loaded	O
onto	O
NuPAGE	O
4	O
–	O
12	O
%	O
gels	O
(	O
Invitrogen	O
)	O
and	O
visualized	O
with	O
silver	O
staining	O
(	O
Pierce	O
Silver	O
Stain	O
Kit	O
)	O
or	O
were	O
subjected	O
to	O
western	O
blot	O
.	O

The	O
potential	O
interacting	O
proteins	O
in	O
specific	O
bands	O
were	O
evaluated	O
with	O
mass	O
spectrum	O
analysis	O
.	O

In	O
vitro	O
kinase	B-GP
and	O
phosphatase	B-GP
assay	O

His	O
-	O
nucleolin	B-GP
was	O
expressed	O
in	O
Sf9	O
cells	O
and	O
purified	O
using	O
Ni	O
-	O
NTA	O
agarose	O
(	O
Qiagen	O
).	O

Control	O
FLAG	O
peptides	O
,	O
FLAG	O
-	O
CDK1	B-GP
and	O
FLAG	O
-	O
PTENβ	B-GP
were	O
purified	O
with	O
ANTI	O
-	O
FLAG	O
M2	O
Affinity	O
Gel	O
(	O
F2426	O
)	O
and	O
3	O
×	O
FLAG	O
Peptide	O
(	O
F4799	O
)	O
from	O
HEK	O
293T	O
cells	O
after	O
transfection	O
with	O
pCMV	O
vector	O
,	O
pCMV	O
-	O
CDK1	B-GP
or	O
pCMV	O
-	O
PTENβ	B-GP
for	O
30	O
h	O
.	O

For	O
kinase	B-GP
assay	O
,	O
purified	O
His	O
-	O
nucleolin	B-GP
on	O
Ni	O
-	O
NTA	O
agarose	O
was	O
incubated	O
with	O
CDK1	B-GP
in	O
kinase	B-GP
buffer	O
(	O
50	O
mM	O
Tris	O
-	O
HCl	O
,	O
10	O
mM	O
MgCl2	O
,	O
2	O
mM	O
DTT	O
,	O
1	O
mM	O
EGTA	O
and	O
0	O
.	O
2	O
mM	O
ATP	O
)	O
for	O
30	O
min	O
at	O
30	O
°	O
C	O
.	O

For	O
the	O
following	O
phosphatase	B-GP
assay	O
,	O
phosphorylated	O
His	O
-	O
nucleolin	B-GP
was	O
incubated	O
with	O
control	O
FLAG	O
peptide	O
or	O
purified	O
FLAG	O
-	O
PTENβ	B-GP
in	O
dephosphorylation	O
buffer	O
(	O
20	O
mM	O
HEPES	O
,	O
1	O
mM	O
MgCl2	O
,	O
1	O
mM	O
EDTA	O
,	O
1	O
mM	O
DTT	O
and	O
0	O
.	O
1	O
mg	O
ml	O
−	O
1	O
BSA	B-GP
)	O
for	O
1	O
h	O
at	O
37	O
°	O
C	O
.	O

The	O
phosphorylation	O
levels	O
of	O
nucleolin	B-GP
sites	O
with	O
potential	O
for	O
alteration	O
were	O
evaluated	O
with	O
western	O
blot	O
.	O

Functional	O
pathway	O
enrichment	O
analysis	O
and	O
visualization	O

Gene	O
Ontology	O
(	O
GO	O
)	O
and	O
KEGG	O
enrichment	O
analysis	O
were	O
performed	O
using	O
ClueGo	O
(	O
ref	O
.	O
55	O
),	O
which	O
is	O
a	O
Cytoscape	O
plug	O
-	O
in	O
.	O

During	O
analysis	O
,	O
over	O
-	O
represented	O
terms	O
in	O
KEGG	O
and	O
the	O
GO	O
Biological	O
Process	O
and	O
Cellular	O
Component	O
were	O
enriched	O
,	O
and	O
the	O
GO	O
level	O
was	O
set	O
at	O
three	O
to	O
five	O
.	O

The	O
GO	O
term	O
fusion	O
option	O
was	O
selected	O
to	O
reduce	O
redundancy	O
.	O

In	O
order	O
to	O
account	O
for	O
multiple	O
testing	O
,	O
P	O
values	O
were	O
corrected	O
with	O
Benjamini	O
-	O
Hochberg	O
correction	O
.	O

Only	O
terms	O
of	O
P	O
<	O
0	O
.	O
05	O
were	O
displayed	O
.	O

The	O
selection	O
criteria	O
for	O
the	O
terms	O
that	O
have	O
associated	O
genes	O
from	O
the	O
uploaded	O
pull	O
down	O
list	O
was	O
set	O
as	O
a	O
minimum	O
of	O
two	O
genes	O
per	O
term	O
,	O
and	O
a	O
minimum	O
of	O
4	O
%	O
of	O
total	O
genes	O
associated	O
with	O
the	O
term	O
for	O
the	O
analysis	O
of	O
the	O
PTENβ	B-GP
pull	O
down	O
network	O
.	O

The	O
Kappa	O
score	O
was	O
set	O
at	O
0	O
.	O
4	O
.	O

Luciferase	B-GP
reporter	O
assay	O
and	O
real	O
-	O
time	O
PCR	O

For	O
luciferase	B-GP
reporter	O
assays	O
,	O
after	O
transfection	O
of	O
various	O
combinations	O
of	O
control	O
,	O
reporter	O
or	O
protein	O
expression	O
vectors	O
for	O
24	O
h	O
,	O
cells	O
were	O
lysed	O
with	O
a	O
passive	O
lysis	O
buffer	O
(	O
Promega	O
).	O

Luciferase	B-GP
activity	O
was	O
measured	O
with	O
the	O
Dual	O
Luciferase	B-GP
Assay	O
System	O
(	O
Promega	O
)	O
following	O
the	O
manufacturer	O
'	O
s	O
protocol	O
.	O

For	O
quantification	O
of	O
45S	O
pre	O
-	O
rRNA	O
,	O
total	O
RNA	O
was	O
extracted	O
from	O
cells	O
followed	O
by	O
reverse	O
transcription	O
and	O
evaluated	O
with	O
qPCR	O
.	O

The	O
qPCR	O
primers	O
used	O
are	O
listed	O
in	O
Supplementary	O
Table	O
4	O
.	O

Silver	O
staining	O
assay	O

Silver	O
staining	O
assays	O
were	O
performed	O
as	O
previously	O
described56	O
.	O

Briefly	O
,	O
cells	O
were	O
seeded	O
onto	O
glass	O
coverslips	O
overnight	O
and	O
were	O
then	O
fixed	O
in	O
2	O
%	O
glutaraldehyde	O
,	O
followed	O
by	O
postfixation	O
in	O
a	O
3	O
:	O
1	O
ethanol	O
–	O
acetic	O
acid	O
solution	O
.	O

Cells	O
were	O
stained	O
with	O
a	O
0	O
.	O
33	O
%	O
formic	O
acid	O
–	O
33	O
.	O
3	O
%	O
silver	O
nitrate	O
solution	O
in	O
0	O
.	O
66	O
%	O
gelatin	O
and	O
mounted	O
on	O
slides	O
with	O
Vectashield	O
(	O
Vector	O
Labs	O
).	O

Nucleolar	O
area	O
was	O
measured	O
in	O
cells	O
with	O
cellSens	O
software	O
provided	O
by	O
Olympus	O
.	O

BrdU	O
incorporation	O
and	O
cell	O
cycle	O
analysis	O

For	O
Brdu	O
incorporation	O
,	O
cells	O
were	O
stained	O
using	O
the	O
APC	O
Brdu	O
Flow	O
Kit	O
(	O
BD	O
Bioscience	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
and	O
subjected	O
to	O
analysis	O
using	O
FACSVerse	O
(	O
BD	O
Biosciences	O
).	O

Experiments	O
were	O
each	O
performed	O
three	O
times	O
,	O
and	O
at	O
least	O
104	O
cells	O
were	O
analysed	O
per	O
sample	O
.	O

Statistical	O
analysis	O

Prism	O
GraphPad	O
software	O
v5	O
.	O
0	O
was	O
used	O
for	O
analysis	O
.	O

The	O
statistical	O
significance	O
of	O
differences	O
between	O
different	O
groups	O
was	O
calculated	O
with	O
the	O
two	O
-	O
tailed	O
paired	O
t	O
-	O
test	O
.	O
P	O
values	O
of	O
0	O
.	O
05	O
or	O
less	O
were	O
considered	O
significant	O
.	O

Data	O
availability	O

Nucleotide	O
sequence	O
data	O
reported	O
in	O
this	O
work	O
are	O
available	O
in	O
the	O
Genebank	O
databases	O
under	O
the	O
accession	O
numbers	O
KX398936	O
(	O
Homo	B-OG
sapiens	I-OG
)	O
and	O
KX421108	O
(	O
Mus	B-OG
musculus	I-OG
).	O

The	O
mass	O
spectrometry	O
proteomics	O
data	O
have	O
been	O
deposited	O
to	O
the	O
ProteomeXchange	O
Consortium	O
(	O
http	O
://	O
proteomecentral	O
.	O
proteomexchange	O
.	O
org	O
/	O
cgi	O
/	O
GetDataset	O
)	O
via	O
the	O
PRIDE	O
(	O
ref	O
.	O
57	O
)	O
partner	O
repository	O
with	O
the	O
data	O
set	O
identifier	O
PXD003850	O
.	O

The	O
original	O
immunoblots	O
,	O
polyacrylamide	O
gels	O
and	O
agarose	O
gels	O
are	O
provided	O
as	O
Supplementary	O
Figs	O
12	O
–	O
15	O
.	O

Primers	O
used	O
in	O
this	O
study	O
are	O
listed	O
in	O
Supplementary	O
Tables	O
2	O
–	O
4	O
.	O

All	O
other	O
data	O
supporting	O
the	O
findings	O
of	O
this	O
study	O
are	O
available	O
within	O
the	O
article	O
and	O
its	O
Supplementary	O
Information	O
or	O
from	O
the	O
corresponding	O
author	O
on	O
reasonable	O
request	O
.	O

Additional	O
information	O

How	O
to	O
cite	O
this	O
article	O
:	O
Liang	O
,	O
H	O
.	O
et	O
al	O
.	O

PTENβ	B-GP
is	O
an	O
alternatively	O
translated	O
isoform	O
of	O
PTEN	B-GP
that	O
regulates	O
rDNA	O
transcription	O
.	O
Nat	O
.	O

Commun	O
.	O
8	O
,	O
14771	O
doi	O
:	O
10	O
.	O
1038	O
/	O
ncomms14771	O
(	O
2017	O
).	O

Publisher	O
'	O
s	O
note	O
:	O
Springer	O
Nature	O
remains	O
neutral	O
with	O
regard	O
to	O
jurisdictional	O
claims	O
in	O
published	O
maps	O
and	O
institutional	O
affiliations	O
.	O

Supplementary	O
Material	O

Supplementary	O
Information	O

Supplementary	O
Figures	O
,	O
Supplementary	O
Tables	O
and	O
Supplementary	O
References	O

Peer	O
Review	O
File	O

The	O
authors	O
declare	O
no	O
competing	O
financial	O
interests	O
.	O

Author	O
contributions	O
Y	O
.	O
Y	O
.	O
and	O
H	O
.	O
L	O
.	O
conceived	O
the	O
study	O
.	O

H	O
.	O
L	O
.	O
and	O
Q	O
.	O
Y	O
.	O
wrote	O
the	O
article	O
.	O

H	O
.	O
L	O
.,	O
X	O
.	O
C	O
.	O
and	O
Q	O
.	O
Y	O
.	O
designed	O
and	O
performed	O
the	O
experiments	O
and	O
analysed	O
the	O
data	O
.	O

D	O
.	O
R	O
.	O
performed	O
several	O
experiments	O
.	O

X	O
.	O
Z	O
.	O
performed	O
mass	O
spectrometric	O
analysis	O
.	O

C	O
.	O
Z	O
.	O
performed	O
functional	O
pathway	O
enrichment	O
analysis	O
.	O

Y	O
.	O
Y	O
.	O
and	O
M	O
.	O
A	O
.	O
M	O
.	O
revised	O
the	O
manuscript	O
.	O

(	O
a	O
)	O
Western	O
blot	O
of	O
PTENα	O
and	O
PTEN	O
in	O
Hela	O
cells	O
after	O
acriflavin	O
treatment	O
at	O
different	O
doses	O
with	O
a	O
polyclonal	O
antibody	O
against	O
full	O
-	O
length	O
PTEN	O
.	O

PTEN	O
immunoblotting	O
revealed	O
an	O
unknown	O
band	O
with	O
a	O
molecular	O
weight	O
lower	O
than	O
PTENα	O
.	O

Quantification	O
of	O
indicated	O
protein	O
levels	O
relative	O
to	O
GAPDH	O
is	O
shown	O
(	O
right	O
panel	O
).	O

(	O
b	O
)	O
Western	O
blot	O
of	O
PTENα	O
and	O
PTEN	O
in	O
a	O
panel	O
of	O
human	O
cancer	O
cell	O
lines	O
using	O
a	O
rabbit	O
monoclonal	O
antibody	O
against	O
the	O
C	O
-	O
terminal	O
region	O
of	O
PTEN	O
(	O
Cell	O
Signaling	O
,	O
138G6	O
).	O

The	O
PTEN	O
null	O
prostate	O
cancer	O
cell	O
line	O
PC3	O
was	O
used	O
as	O
a	O
negative	O
control	O
.	O

(	O
c	O
)	O
Immunoprecipitation	O
of	O
PTENα	O
with	O
a	O
homemade	O
PTENα	O
antibody	O
before	O
PTEN	O
immunoblotting	O
of	O
SMMC	O
-	O
7721	O
and	O
HCT116	O
cells	O
of	O
known	O
PTEN	O
status	O
.	O

(	O
a	O
)	O
The	O
potential	O
non	O
-	O
AUG	O
initiation	O
codons	O
in	O
favourable	O
Kozak	O
contexts	O
in	O
the	O
5	O
′	O
UTR	O
region	O
of	O
Homo	O
sapiens	O
PTEN	O
mRNA	O
are	O
highlighted	O
in	O
red	O
.	O

The	O
initiation	O
codons	O
of	O
PTENα	O
and	O
PTEN	O
are	O
separately	O
highlighted	O
in	O
yellow	O
or	O
green	O
.	O

(	O
b	O
)	O
A	O
pEGFP	O
-	O
N1	O
plasmid	O
containing	O
PTENα	O
with	O
a	O
C	O
-	O
terminal	O
GFP	O
tag	O
was	O
used	O
for	O
detection	O
of	O
PTENα	O
,	O
PTEN	O
and	O
unknown	O
PTEN	O
isoforms	O
(	O
upper	O
panel	O
);	O
the	O
indicated	O
plasmids	O
were	O
introduced	O
in	O
HEK	O
293T	O
cells	O
followed	O
by	O
western	O
blotting	O
analysis	O
using	O
GFP	O
antibody	O
.	O
β	O
-	O
tubulin	O
was	O
used	O
as	O
a	O
control	O
(	O
lower	O
panel	O
).	O

(	O
c	O
)	O
pEGFP	O
-	O
N1	O
plasmids	O
containing	O
PTEN	O
or	O
PTENα	O
with	O
a	O
C	O
-	O
terminal	O
GFP	O
tag	O
,	O
in	O
which	O
one	O
of	O
the	O
two	O
potential	O
initiation	O
codons	O
(	O
AUU594	O
or	O
UUG621	O
)	O
was	O
mutated	O
to	O
CUC	O
combined	O
with	O
mutation	O
of	O
CUG513	O
.	O

(	O
d	O
)	O
Mutation	O
of	O
AUU594	O
but	O
not	O
UUG621	O
eliminates	O
PTENβ	O
expression	O
.	O

Plasmids	O
as	O
indicated	O
in	O
c	O
were	O
introduced	O
into	O
HEK	O
293T	O
cells	O
separately	O
,	O
followed	O
by	O
immunoblotting	O
with	O
GFP	O
antibody	O
.	O

(	O
e	O
)	O
The	O
Kozak	O
context	O
of	O
AUU594	O
and	O
disruption	O
of	O
the	O
Kozak	O
context	O
by	O
site	O
directed	O
mutagenesis	O
.	O

(	O
f	O
)	O
The	O
Kozak	O
context	O
disruption	O
abolishes	O
PTENβ	O
expression	O
.	O

HEK	O
293T	O
cells	O
were	O
transfected	O
with	O
indicated	O
constructs	O
in	O
e	O
,	O
followed	O
by	O
immunoblotting	O
with	O
GFP	O
antibody	O
.	O

(	O
g	O
)	O
A	O
12	O
bp	O
AUU594	O
downstream	O
palindromic	O
motif	O
in	O
the	O
5	O
′	O
UTR	O
of	O
PTEN	O
is	O
evolutionarily	O
conserved	O
.	O

Phylogenetic	O
analysis	O
of	O
the	O
5	O
′	O
UTR	O
of	O
PTEN	O
mRNA	O
in	O
bonobo	O
(	O
Pan	O
paniscus	O
),	O
killer	O
whale	O
(	O
Orcinus	O
orca	O
)	O
and	O
mouse	O
(	O
Mus	O
musculus	O
).	O

The	O
alternative	O
CUG513	O
and	O
AUU594	O
codons	O
are	O
highlighted	O
in	O
blue	O
boxes	O
,	O
and	O
the	O
12	O
bp	O
palindromic	O
sequence	O
is	O
highlighted	O
in	O
a	O
red	O
box	O
.	O

(	O
h	O
)	O
Disruption	O
of	O
the	O
palindromic	O
motif	O
abolishes	O
PTENβ	O
expression	O
.	O

Upper	O
panel	O
,	O
site	O
directed	O
mutagnesis	O
was	O
used	O
to	O
disrupt	O
the	O
AUU594	O
downstream	O
palindromic	O
motif	O
;	O
lower	O
panel	O
,	O
C	O
-	O
terminal	O
GFP	O
-	O
tagged	O
PTENβ	O
expression	O
plasmids	O
with	O
or	O
without	O
disruption	O
of	O
the	O
palindromic	O
motif	O
were	O
introduced	O
into	O
HEK	O
293T	O
cells	O
,	O
followed	O
by	O
immunoblotting	O
with	O
GFP	O
antibody	O
.	O

(	O
a	O
)	O
A	O
pFastBac1	O
plasmid	O
containing	O
PTENα	O
with	O
a	O
C	O
-	O
terminal	O
His	O
-	O
tag	O
was	O
used	O
for	O
in	O
vitro	O
purification	O
of	O
PTENβ	O
.	O

The	O
PTEN	O
AUG	O
start	O
codon	O
was	O
mutated	O
to	O
AUA	O
and	O
the	O
PTENα	O
CUG	O
start	O
codon	O
was	O
mutated	O
to	O
CUC	O
to	O
avoid	O
co	O
-	O
purification	O
of	O
PTEN	O
and	O
PTENα	O
with	O
PTENβ	O
.	O

(	O
b	O
)	O
Mass	O
spectrometry	O
analysis	O
of	O
purified	O
PTENβ	O
.	O

Sf9	O
-	O
expressed	O
PTENβ	O
with	O
a	O
C	O
-	O
terminal	O
His	O
-	O
tag	O
was	O
purified	O
using	O
nickel	O
affinity	O
chromatography	O
.	O

The	O
bound	O
proteins	O
were	O
separated	O
with	O
SDS	O
–	O
PAGE	O
,	O
and	O
gel	O
slices	O
at	O
around	O
70	O
kDa	O
(	O
red	O
box	O
)	O
were	O
analysed	O
by	O
mass	O
spectrometry	O
.	O

Three	O
segments	O
of	O
peptide	O
that	O
match	O
the	O
5	O
′	O
UTR	O
region	O
of	O
PTEN	O
were	O
identified	O
,	O
including	O
the	O
most	O
proximal	O
N	O
-	O
terminal	O
peptide	O
of	O
PTENβ	O
MSRAGNAGE	O
.	O

(	O
c	O
)	O
The	O
MS	O
/	O
MS	O
spectrum	O
of	O
the	O
most	O
proximal	O
N	O
-	O
terminal	O
peptide	O
of	O
PTENβ	O
MSRAGNAGE	O
.	O

(	O
d	O
)	O
Verification	O
of	O
endogenous	O
PTENβ	O
expression	O
in	O
Pten	O
-	O
FLAG	O
knockin	O
mice	O
.	O

Various	O
tissues	O
from	O
Pten	O
-	O
FLAG	O
knockin	O
mice	O
were	O
lysed	O
for	O
immunoprecipitation	O
with	O
FLAG	O
antibody	O
,	O
followed	O
by	O
immunoblotting	O
with	O
PTENα	O
antibody	O
raised	O
in	O
our	O
laboratory	O
.	O

Wild	O
-	O
type	O
mice	O
tissues	O
were	O
used	O
as	O
control	O
.	O

(	O
e	O
)	O
Brain	O
tissues	O
from	O
Pten	O
-	O
FLAG	O
knockin	O
mice	O
or	O
control	O
wild	O
-	O
type	O
mice	O
were	O
lysed	O
for	O
immunoprecipitation	O
with	O
anti	O
-	O
FLAG	O
M2	O
agarose	O
.	O

The	O
bound	O
proteins	O
were	O
separated	O
with	O
SDS	O
–	O
PAGE	O
.	O

Mass	O
spectrometry	O
analysis	O
of	O
gel	O
slices	O
at	O
around	O
70	O
kDa	O
(	O
molecular	O
weight	O
lower	O
than	O
PTENα	O
)	O
revealed	O
four	O
peptides	O
in	O
Pten	O
-	O
FLAG	O
knockin	O
tissues	O
that	O
matched	O
the	O
PTENβ	O
N	O
-	O
terminal	O
extended	O
region	O
.	O

(	O
a	O
)	O
A	O
set	O
of	O
different	O
constructs	O
of	O
PTEN	O
,	O
PTENα	O
and	O
PTENβ	O
with	O
a	O
C	O
-	O
terminal	O
GFP	O
tag	O
.	O

The	O
AUG	O
start	O
codon	O
of	O
canonical	O
PTEN	O
was	O
mutated	O
to	O
AUA	O
in	O
PTENα	O
and	O
PTENβ	O
constructs	O
in	O
order	O
to	O
abolish	O
expression	O
of	O
canonical	O
PTEN	O
.	O

(	O
b	O
)	O
Subcellular	O
localization	O
of	O
C	O
-	O
terminal	O
GFP	O
-	O
tagged	O
PTENα	O
,	O
PTENβ	O
and	O
PTEN	O
.	O

The	O
constructs	O
indicated	O
in	O
a	O
were	O
introduced	O
into	O
Hela	O
PTEN	O
null	O
cells	O
.	O

Twenty	O
-	O
four	O
hours	O
after	O
transfection	O
,	O
cells	O
were	O
stained	O
with	O
DAPI	O
,	O
followed	O
by	O
imaging	O
with	O
confocal	O
microscopy	O
.	O

The	O
scale	O
bars	O
represent	O
5	O
μm	O
.	O

(	O
c	O
)	O
Hela	O
PTEN	O
null	O
cells	O
were	O
transfected	O
as	O
in	O
b	O
,	O
then	O
stained	O
with	O
an	O
anti	O
-	O
UBF	O
antibody	O
and	O
DAPI	O
,	O
and	O
imaged	O
with	O
confocal	O
microscopy	O
.	O

The	O
scale	O
bars	O
represent	O
5	O
μm	O
.	O

(	O
d	O
)	O
Hela	O
cells	O
were	O
transfected	O
with	O
C	O
-	O
terminal	O
GFP	O
-	O
tagged	O
PTENβ	O
,	O
and	O
subjected	O
to	O
cell	O
fractionation	O
,	O
followed	O
by	O
western	O
blotting	O
with	O
GFP	O
,	O
nucleolin	O
,	O
HDAC1	O
and	O
HSP90	O
antibodies	O
.	O

WCE	O
:	O
whole	O
cell	O
lysate	O
.	O

(	O
e	O
)	O
Hela	O
PTEN	O
null	O
cells	O
were	O
transfected	O
with	O
C	O
-	O
terminal	O
GFP	O
-	O
tagged	O
PTENβ	O
or	O
C	O
-	O
terminal	O
GFP	O
-	O
tagged	O
PTENβΔR6	O
.	O

Twenty	O
-	O
four	O
hours	O
after	O
transfection	O
,	O
cells	O
were	O
stained	O
with	O
anti	O
-	O
UBF	O
antibody	O
and	O
DAPI	O
,	O
followed	O
by	O
imaging	O
with	O
confocal	O
microscopy	O
.	O

The	O
scale	O
bars	O
represent	O
5	O
μm	O
.	O

(	O
a	O
)	O
In	O
vivo	O
S	O
-	O
tag	O
pull	O
-	O
down	O
analysis	O
.	O

Whole	O
cell	O
extracts	O
from	O
HEK	O
293T	O
cells	O
transfected	O
with	O
S	O
-	O
tagged	O
-	O
PTEN	O
,	O
S	O
-	O
tagged	O
-	O
PTENα	O
,	O
S	O
-	O
tagged	O
-	O
PTENβ	O
or	O
mock	O
constructs	O
were	O
immunoprecipitated	O
with	O
S	O
-	O
protein	O
beads	O
followed	O
by	O
mass	O
spectrometric	O
peptide	O
sequencing	O
.	O

Nucleolin	O
was	O
found	O
in	O
the	O
PTENβ	O
pull	O
-	O
down	O
list	O
.	O

(	O
b	O
,	O
c	O
)	O
Reciprocal	O
immunoprecipitation	O
of	O
PTENβ	O
and	O
nucleolin	O
.	O

(	O
b	O
)	O
C	O
-	O
terminal	O
GFP	O
-	O
tagged	O
PTENβ	O
or	O
GFP	O
-	O
tagged	O
mock	O
was	O
transfected	O
,	O
followed	O
by	O
immunoprecipitation	O
with	O
GFP	O
antibody	O
and	O
immunoblotting	O
with	O
an	O
anti	O
-	O
nucleolin	O
antibody	O
.	O

(	O
c	O
)	O
FLAG	O
-	O
tagged	O
nucleolin	O
or	O
mock	O
plasmid	O
was	O
co	O
-	O
transfected	O
with	O
GFP	O
-	O
tagged	O
PTENβ	O
,	O
followed	O
by	O
immunoprecipitation	O
with	O
FLAG	O
antibody	O
and	O
immunoblotting	O
with	O
GFP	O
antibody	O
.	O

(	O
d	O
)	O
Images	O
of	O
immunofluorescence	O
staining	O
for	O
PTENβ	O
and	O
nucleolin	O
.	O

Hela	O
PTEN	O
null	O
cells	O
were	O
transfected	O
as	O
in	O
Fig	O
.	O
4b	O
,	O
followed	O
by	O
staining	O
with	O
an	O
anti	O
-	O
nucleolin	O
antibody	O
,	O
and	O
were	O
imaged	O
by	O
confocal	O
microscopy	O
.	O

The	O
scale	O
bars	O
represent	O
5	O
μm	O
.	O

(	O
e	O
)	O
PTENβ	O
protein	O
phosphatase	O
activity	O
is	O
required	O
for	O
its	O
interaction	O
with	O
nucleolin	O
.	O

Wild	O
-	O
type	O
PTENβ	O
or	O
PTENβ	O
mutants	O
as	O
indicated	O
in	O
Supplementary	O
Fig	O
.	O
6b	O
was	O
transfected	O
separately	O
,	O
followed	O
by	O
immunoprecipitation	O
with	O
GFP	O
antibody	O
and	O
immunoblotting	O
with	O
an	O
anti	O
-	O
nucleolin	O
antibody	O
.	O

(	O
f	O
)	O
Schematic	O
strategy	O
of	O
PTENβ	O
CRISPR	O
-	O
Cas9	O
knockout	O
.	O

The	O
initiation	O
codons	O
of	O
PTEN	O
isoforms	O
were	O
labelled	O
.	O

(	O
g	O
)	O
Immunoblot	O
confirming	O
abolition	O
of	O
PTENα	O
only	O
(	O
lane	O
2	O
),	O
or	O
PTENα	O
and	O
PTENβ	O
double	O
knockout	O
(	O
lane	O
3	O
)	O
with	O
a	O
PTEN	O
antibody	O
.	O

(	O
h	O
)	O
Phospho	O
-	O
nucleolin	O
level	O
in	O
PTENβ	O
knockout	O
cells	O
.	O

PTENβ	O
knockout	O
cells	O
as	O
indicated	O
in	O
f	O
,	O
g	O
were	O
lysed	O
,	O
followed	O
by	O
immunoblotting	O
with	O
p	O
-	O
nucleolin	O
(	O
Thr	O
84	O
),	O
nucleolin	O
or	O
β	O
-	O
actin	O
antibody	O
.	O

Experiments	O
were	O
carried	O
out	O
in	O
three	O
biological	O
replicates	O
and	O
quantification	O
of	O
indicated	O
protein	O
levels	O
relative	O
to	O
β	O
-	O
actin	O
is	O
shown	O
.	O

Bars	O
represent	O
mean	O
±	O
s	O
.	O
e	O
.	O
m	O
.	O

(	O
i	O
)	O
C	O
-	O
terminal	O
GFP	O
-	O
tagged	O
wild	O
-	O
type	O
PTENβ	O
or	O
PTENβ	O
mutants	O
as	O
indicated	O
in	O
e	O
were	O
introduced	O
into	O
PTENα	O
and	O
PTENβ	O
double	O
knockout	O
cells	O
as	O
indicated	O
in	O
g	O
,	O
followed	O
by	O
immunoblotting	O
with	O
p	O
-	O
nucleolin	O
(	O
Thr	O
84	O
),	O
nucleolin	O
or	O
GFP	O
antibody	O
.	O

(	O
j	O
)	O
Purified	O
nucleolin	O
was	O
phosphorylated	O
in	O
vitro	O
by	O
Cdk1	O
/	O
CyclinB1	O
and	O
subsequently	O
used	O
in	O
a	O
phosphatase	O
assay	O
with	O
FLAG	O
-	O
PTENβ	O
or	O
FLAG	O
peptide	O
alone	O
as	O
a	O
control	O
,	O
followed	O
by	O
immunoblotting	O
with	O
p	O
-	O
nucleolin	O
(	O
Thr	O
84	O
).	O

(	O
a	O
,	O
b	O
)	O
28S	O
and	O
18S	O
rRNA	O
levels	O
in	O
PTENβ	O
knockout	O
cells	O
.	O

(	O
a	O
)	O
Total	O
RNA	O
was	O
extracted	O
from	O
wild	O
-	O
type	O
Hela	O
cells	O
and	O
knockout	O
cells	O
as	O
indicated	O
in	O
Fig	O
.	O
5g	O
,	O
followed	O
by	O
resolution	O
on	O
a	O
1	O
%	O
formaldehyde	O
-	O
agarose	O
gel	O
for	O
comparison	O
.	O

(	O
b	O
)	O
Exogenous	O
PTENα	O
or	O
PTENβ	O
was	O
transfected	O
into	O
PTENα	O
and	O
PTENβ	O
double	O
knockout	O
cells	O
as	O
indicated	O
in	O
Fig	O
.	O
5g	O
,	O
followed	O
by	O
resolution	O
on	O
a	O
1	O
%	O
formaldehyde	O
-	O
agarose	O
gel	O
for	O
comparison	O
.	O

Grey	O
scale	O
quantification	O
results	O
of	O
total	O
28S	O
rRNA	O
and	O
18S	O
rRNA	O
levels	O
are	O
shown	O
.	O

(	O
c	O
)	O
45S	O
pre	O
-	O
rRNA	O
level	O
in	O
PTENβ	O
knockout	O
cells	O
as	O
indicated	O
in	O
Fig	O
.	O
5g	O
.	O

(	O
d	O
)	O
rDNA	O
promoter	O
luciferase	O
reporter	O
activity	O
in	O
HeLa	O
cells	O
.	O

PTENα	O
and	O
PTENβ	O
double	O
knockout	O
cells	O
as	O
indicated	O
in	O
Fig	O
.	O
5g	O
were	O
co	O
-	O
transfected	O
with	O
pHrD	O
-	O
IRES	O
-	O
Luc	O
or	O
pGL3	O
-	O
basic	O
plasmid	O
and	O
exogenous	O
PTENα	O
or	O
PTENβ	O
.	O

Luciferase	O
activity	O
was	O
measured	O
24	O
h	O
after	O
transfection	O
.	O

(	O
e	O
)	O
Average	O
area	O
of	O
nucleolar	O
organizing	O
regions	O
in	O
cells	O
as	O
indicated	O
in	O
Fig	O
.	O
5g	O
.	O

Left	O
panel	O
,	O
images	O
of	O
silver	O
staining	O
.	O

Right	O
panel	O
,	O
quantitative	O
analysis	O
of	O
AgNOR	O
indices	O
.	O

AgNOR	O
from	O
50	O
cells	O
were	O
measured	O
in	O
each	O
group	O
.	O

The	O
scale	O
bars	O
represent	O
10	O
μm	O
.	O

(	O
f	O
)	O
Cell	O
growth	O
curves	O
in	O
cells	O
as	O
indicated	O
in	O
Fig	O
.	O
5g	O
.	O

One	O
thousand	O
cells	O
were	O
plated	O
per	O
well	O
in	O
96	O
-	O
well	O
plates	O
in	O
triplicate	O
.	O

Quantification	O
was	O
performed	O
every	O
24	O
h	O
for	O
5	O
days	O
following	O
the	O
instructions	O
for	O
the	O
Cell	O
Titer	O
96	O
AQueous	O
One	O
Solution	O
Cell	O
Proliferation	O
Assay	O
Kit	O
.	O

The	O
significance	O
of	O
the	O
difference	O
in	O
PTENα	O
and	O
PTENβ	O
double	O
knockout	O
and	O
wild	O
-	O
type	O
Hela	O
cells	O
is	O
shown	O
with	O
red	O
asterisks	O
,	O
and	O
the	O
significance	O
of	O
the	O
difference	O
in	O
PTENα	O
only	O
knockout	O
and	O
wild	O
-	O
type	O
cells	O
is	O
shown	O
with	O
green	O
asterisks	O
.	O

(	O
g	O
)	O
Detection	O
of	O
S	O
-	O
phase	O
cells	O
using	O
the	O
APC	O
BrdU	O
Flow	O
Kit	O
.	O

Wild	O
-	O
type	O
,	O
PTENα	O
and	O
PTENβ	O
double	O
knockout	O
or	O
PTENα	O
knockout	O
only	O
cells	O
were	O
treated	O
with	O
1	O
mM	O
BrdU	O
,	O
followed	O
by	O
staining	O
with	O
fluorochrome	O
-	O
conjugated	O
anti	O
-	O
Brdu	O
antibody	O
and	O
evaluation	O
with	O
flow	O
cytometry	O
.	O

Data	O
are	O
presented	O
as	O
mean	O
±	O
s	O
.	O
e	O
.	O
m	O
.	O
of	O
three	O
independent	O
experiments	O
and	O
were	O
analysed	O
with	O
the	O
paired	O
t	O
-	O
test	O
.	O
*	O
P	O
<	O
0	O
.	O
05	O
;	O
**	O
P	O
<	O
0	O
.	O
01	O
;	O
***	O
P	O
<	O
0	O
.	O
001	O
;	O
****	O
P	O
<	O
0	O
.	O
0001	O
.	O

